A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the TSETSE FLY. Involvement of the central nervous system produces "African sleeping sickness." Nagana is a rapidly fatal trypanosomiasis of horses and other animals.
Infection with protozoa of the genus TRYPANOSOMA.
Infection in cattle caused by various species of trypanosomes.
A hemoflagellate subspecies of parasitic protozoa that causes Gambian or West African sleeping sickness in humans. The vector host is usually the tsetse fly (Glossina).
Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA.
Arsenical used in trypanosomiases. It may cause fatal encephalopathy and other undesirable side effects.
A hemoflagellate subspecies of parasitic protozoa that causes Rhodesian sleeping sickness in humans. It is carried by Glossina pallidipes, G. morsitans and occasionally other species of game-attacking tsetse flies.
A hemoflagellate subspecies of parasitic protozoa that causes nagana in domestic and game animals in Africa. It apparently does not infect humans. It is transmitted by bites of tsetse flies (Glossina).
A genus of flagellate protozoans found in the blood and lymph of vertebrates and invertebrates, both hosts being required to complete the life cycle.
Bloodsucking flies of the genus Glossina, found primarily in equatorial Africa. Several species are intermediate hosts of trypanosomes.
A species of Trypanosome hemoflagellates that is carried by tsetse flies and causes severe anemia in cattle. These parasites are also found in horses, sheep, goats, and camels.
Persons living in the United States having origins in any of the black groups of Africa.
An active blood parasite that is present in practically all domestic animals in Africa, the West Indies, and parts of Central and South America. In Africa, the insect vector is the tsetse fly. In other countries, infection is by mechanical means indicating that the parasites have been introduced to these countries and have been able to maintain themselves in spite of the lack of a suitable intermediate host. It is a cause of nagana, the severity of which depends on the species affected.
A republic in central Africa, east of the REPUBLIC OF THE CONGO, south of the CENTRAL AFRICAN REPUBLIC and north of ANGOLA and ZAMBIA. The capital is Kinshasa.
A republic in southern Africa, southwest of DEMOCRATIC REPUBLIC OF THE CONGO and west of ZAMBIA. Its capital is Luanda.
Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
A republic in central Africa lying between GABON and DEMOCRATIC REPUBLIC OF THE CONGO and south of Cameroon. Its capital is Brazzaville.
Infections of the brain, spinal cord, or meninges by single celled organisms of the former subkingdom known as protozoa. The central nervous system may be the primary or secondary site of protozoal infection. These diseases may occur as OPPORTUNISTIC INFECTIONS or arise in immunocompetent hosts.
A republic in central Africa south of CHAD and SUDAN, north of DEMOCRATIC REPUBLIC OF THE CONGO, and east of CAMEROON. The capital is Bangui.
A nitrofuran thiazine that has been used against TRYPANOSOMIASIS.
An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
A country in northeastern Africa. The capital is Khartoum.
Substances that are destructive to protozoans.
The reduction or regulation of the population of noxious, destructive, or dangerous insects through chemical, biological, or other means.
I'm afraid there seems to be a misunderstanding - "Africa" is not a medical term and does not have a medical definition. Africa is the world's second-largest and second-most populous continent, consisting of 54 countries with diverse cultures, peoples, languages, and landscapes. If you have any questions related to medical topics or definitions, I would be happy to help answer those for you!
Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.
Individuals whose ancestral origins are in the continent of Africa.
The geographical area of Africa comprising CAMEROON; CENTRAL AFRICAN REPUBLIC; CHAD; CONGO; EQUATORIAL GUINEA; GABON; and DEMOCRATIC REPUBLIC OF THE CONGO.
The agent of South American trypanosomiasis or CHAGAS DISEASE. Its vertebrate hosts are man and various domestic and wild animals. Insects of several species are vectors.
A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
An effective trypanocidal agent.
A republic in eastern Africa, south of SUDAN and west of KENYA. Its capital is Kampala.
Amidines substituted with a benzene group. Benzamidine and its derivatives are known as peptidase inhibitors.
Diseases that are underfunded and have low name recognition but are major burdens in less developed countries. The World Health Organization has designated six tropical infectious diseases as being neglected in industrialized countries that are endemic in many developing countries (HELMINTHIASIS; LEPROSY; LYMPHATIC FILARIASIS; ONCHOCERCIASIS; SCHISTOSOMIASIS; and TRACHOMA).
Glycoproteins attached to the surface coat of the trypanosome. Many of these glycoproteins show amino acid sequence diversity expressed as antigenic variations. This continuous development of antigenically distinct variants in the course of infection ensures that some trypanosomes always survive the development of immune response to propagate the infection.
Tests that demonstrate the relative effectiveness of chemotherapeutic agents against specific parasites.
The study of parasites and PARASITIC DISEASES.
Immunoglobulins produced in a response to PROTOZOAN ANTIGENS.
Tests that are dependent on the clumping of cells, microorganisms, or particles when mixed with specific antiserum. (From Stedman, 26th ed)
A republic in western Africa, south of MALI and BURKINA FASO, bordered by GHANA on the east. Its administrative capital is Abidjan and Yamoussoukro has been the official capital since 1983. The country was formerly called Ivory Coast.
Insects that transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.
A republic in southern Africa, south of DEMOCRATIC REPUBLIC OF THE CONGO and TANZANIA, and north of ZIMBABWE. Its capital is Lusaka. It was formerly called Northern Rhodesia.
The branch of medicine concerned with diseases, mainly of parasitic origin, common in tropical and subtropical regions.
A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.
A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
Invertebrates or non-human vertebrates which transmit infective organisms from one host to another.
Deoxyribonucleic acid that makes up the genetic material of protozoa.
Precipitin tests which occur over a narrow range of antigen-antibody ratio, due chiefly to peculiarities of the antibody (precipitin). (From Stedman, 26th ed)
A republic in west equatorial Africa, south of CAMEROON and west of the CONGO. Its capital is Libreville.
Nitroimidazoles are a class of antibacterial and antiprotozoal drugs, which, upon reduction, interact with bacterial or protozoal DNA leading to inhibition of nucleic acid synthesis and ultimately cell death, used primarily in the treatment of anaerobic infections and certain parasitic diseases.
Infections of the brain, spinal cord, and meninges caused by parasites.
Proteins found in any species of protozoan.
A republic in western Africa, south of SENEGAL and MALI, east of GUINEA-BISSAU. Its capital is Conakry.
A republic in central Africa, east of NIGER, west of SUDAN and south of LIBYA. Its capital is N'Djamena.
All of Africa except Northern Africa (AFRICA, NORTHERN).
The constant presence of diseases or infectious agents within a given geographic area or population group. It may also refer to the usual prevalence of a given disease with such area or group. It includes holoendemic and hyperendemic diseases. A holoendemic disease is one for which a high prevalent level of infection begins early in life and affects most of the child population, leading to a state of equilibrium such that the adult population shows evidence of the disease much less commonly than do children (malaria in many communities is a holoendemic disease). A hyperendemic disease is one that is constantly present at a high incidence and/or prevalence rate and affects all groups equally. (Last, A Dictionary of Epidemiology, 3d ed, p53, 78, 80)
The lone species of the genus Asfivirus. It infects domestic and wild pigs, warthogs, and bushpigs. Disease is endemic in domestic swine in many African countries and Sardinia. Soft ticks of the genus Ornithodoros are also infected and act as vectors.
Domesticated farm animals raised for home use or profit but excluding POULTRY. Typically livestock includes CATTLE; SHEEP; HORSES; SWINE; GOATS; and others.
A republic in southern Africa, the southernmost part of Africa. It has three capitals: Pretoria (administrative), Cape Town (legislative), and Bloemfontein (judicial). Officially the Republic of South Africa since 1960, it was called the Union of South Africa 1910-1960.
Infections or infestations with parasitic organisms. They are often contracted through contact with an intermediate vector, but may occur as the result of direct exposure.
Infections with unicellular organisms formerly members of the subkingdom Protozoa.
The presence of parasites (especially malarial parasites) in the blood. (Dorland, 27th ed)
The primary sore of syphilis, a painless indurated, eroded papule, occurring at the site of entry of the infection.
Aspects of health and disease related to travel.
Amidines are organic compounds containing the functional group consisting of a nitrogen atom connected to two carbon atoms by double bonds, with the remaining two bonds attached to hydrogen and any other organic substituent.
The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
A republic in eastern Africa, south of UGANDA and north of MOZAMBIQUE. Its capital is Dar es Salaam. It was formed in 1964 by a merger of the countries of TANGANYIKA and ZANZIBAR.
Individuals whose ancestral origins are in the continent of Europe.
An inflammatory process involving the brain (ENCEPHALITIS) and meninges (MENINGITIS), most often produced by pathogenic organisms which invade the central nervous system, and occasionally by toxins, autoimmune disorders, and other conditions.
Drugs used to treat or prevent parasitic infections.
Animate or inanimate sources which normally harbor disease-causing organisms and thus serve as potential sources of disease outbreaks. Reservoirs are distinguished from vectors (DISEASE VECTORS) and carriers, which are agents of disease transmission rather than continuing sources of potential disease outbreaks.
Diseases of domestic cattle of the genus Bos. It includes diseases of cows, yaks, and zebus.
A sometimes fatal ASFIVIRUS infection of pigs, characterized by fever, cough, diarrhea, hemorrhagic lymph nodes, and edema of the gallbladder. It is transmitted between domestic swine by direct contact, ingestion of infected meat, or fomites, or mechanically by biting flies or soft ticks (genus Ornithodoros).
Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.
A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Abuja.
A republic in eastern Africa, south of ETHIOPIA, west of SOMALIA with TANZANIA to its south, and coastline on the Indian Ocean. Its capital is Nairobi.
Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications.
Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
Enzymes which reduce nitro groups (NITRO COMPOUNDS) and other nitrogenous compounds.
Infectious diseases that are novel in their outbreak ranges (geographic and host) or transmission mode.
The intergenic DNA segments that are between the ribosomal RNA genes (internal transcribed spacers) and between the tandemly repeated units of rDNA (external transcribed spacers and nontranscribed spacers).
Passive agglutination tests in which antigen is adsorbed onto latex particles which then clump in the presence of antibody specific for the adsorbed antigen. (From Stedman, 26th ed)
Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered.

Human African trypanosomiasis: a latex agglutination field test for quantifying IgM in cerebrospinal fluid. (1/808)

LATEX/IgM, a rapid agglutination test for the semi-quantitative detection of IgM in cerebrospinal fluid of patients with African trypanosomiasis, is described in this article. The lyophilized reagent has been designed for field use and remains stable at 45 degrees C for one year. The test has been evaluated on cerebrospinal fluid samples from trypanosome-infected and non-infected patients, by comparison with commercial latex agglutination, radial immunodiffusion, and nephelometry. All test systems yielded similar results.  (+info)

Upregulation of the chemokines Rantes, MCP-1, MIP-1a and MIP-2 in early infection with Trypanosoma brucei brucei and inhibition by sympathetic denervation of the spleen. (2/808)

We examined the induction of 4 chemokines during early experimental African trypanosomiasis using in situ hybridization and immunocytochemistry. mRNA expression and protein production of Rantes, MCP-1, MIP-1a and MIP-2 were studied in splenocytes obtained at 0 h, 4 h and 12 h post-infection. Splenic denervation was performed to study the role of the central nervous system in early infection. The mRNA for Rantes increased at 4 h and declined at 12 h, but the protein level was high at both time-points. MCP-1 and MIP-la had elevated mRNA and protein levels at 12 h post-infection. MIP-2 mRNA was high at both 4 h and 12 h, but the protein level was only increased at 12 h. Splenic denervation, but not sham operation, suppressed these responses. The upregulation of these chemokines during very early infection suggests a chemokine role in the developing immunopathology The sympathetic nervous system may, however, participate in modulation of such early immune responses.  (+info)

Induction of the trypanosome lymphocyte-triggering factor (TLTF) and neutralizing antibodies to the TLTF in experimental african trypanosomiasis. (3/808)

We have demonstrated that African trypanosomes secrete a novel trypanokine, the trypanosome-derived lymphocyte-triggering factor (TLTF), which activates CD8+ cells to produce interferon-gamma (IFN-gamma) that in turn stimulates parasite growth. The gene for TLTF was recently cloned, and recombinant TLTF (rTLTF) showed bioactivity that was similar to native TLTF. In this work, we employed two anti-TLTF monoclonal antibodies (mAbs) to detect levels of TLTF during Trypanosoma brucei brucei (T. b. brucei ) infections in mice. Furthermore, rTLTF was utilized to assess levels of anti-TLTF antibodies. Mice with intact genes (wild type), and knockout mice with disrupted IFN-gamma (IFN-gamma-/-) or IFN-gammaR (IFN-gammaR-/-) genes were studied. The knockout mice were used in order to illustrate the role of IFN-gamma in the production of antibodies to TLTF. While wild-type mice showed high parasitaemia accompanied by high TLTF levels and low anti-TLTF antibodies at day 3 postinfection (p.i.), low TLTF was measured together with increased anti-TLTF antibodies at day 21 p.i. IFN-gamma-/- mice exhibited very low parasitaemia, TLTF and anti-TLTF antibody levels. In contrast, IFN-gammaR-/- mice revealed very high parasitaemia, increased TLTF levels, but decreased anti-TLTF antibodies. In a biological assay for TLTF, Fab' fragments of anti-TLTF antibodies dose dependently inhibited the TLTF-induced IFN-gamma production by splenocytes, suggesting a regulatory importance of these antibodies. Our data demonstrate a role of IFN-gamma in the generation of neutralizing antibodies to TLTF. Furthermore, the induction of TLTF and its antibodies may constitute a new approach for future diagnosis of African trypanosomiasis.  (+info)

Infection-associated decline of cape buffalo blood catalase augments serum trypanocidal activity. (4/808)

Clearance of trypanosomes from the blood of infected Cape buffalo was associated with the development of two responses: (i) complement-dependent and clone-specific lytic activity and (ii) complement-independent trypanocidal activity that was not restricted by trypanosome clone or species. This latter activity was mediated by H2O2 and required the presence of xanthine oxidase in serum but not the addition of purine substrates. Expression of the xanthine oxidase-dependent trypanocidal activity in Cape buffalo serum was coincident with, and required, a decline in its H2O2 catabolic activity. The H2O2 catabolic activity of Cape buffalo serum was due solely to catalase and declined by eightfold around the time that trypanosomes were cleared from the blood, accompanied by a fivefold drop in erythrocyte-associated catalase activity. The Cape buffalo did not develop subsequent parasitemic waves. Clearance of parasitemia in similarly infected cattle was also associated with development of trypanosome clone-specific lytic activity, but not with the acquisition of H2O2-dependent trypanocidal activity in serum, and the cattle supported recurring parasitemia. The lack of trypanocidal activity in pre- and postinfection cattle sera was due to their low content of xanthine oxidase and sustained catalase activity. These data strongly suggest that an infection-induced serum oxidative response, the efficacy of which is amplified by a decline in blood catalase, contributes to suppression of recurring parasitemia in Cape buffalo.  (+info)

Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections. (5/808)

In order to evaluate during experimental Trypanosoma brucei infections the potential role of tumor necrosis factor alpha (TNF-alpha) in the host-parasite interrelationship, C57BL/6 TNF-alpha knockout mice (TNF-alpha-/-) as well as C57BL/6 wild-type mice were infected with pleomorphic T. brucei AnTat 1.1 E parasites. In the TNF-alpha-/- mice, the peak levels of parasitemia were strongly increased compared to the peak levels recorded in wild-type mice. The increased parasite burden did not reflect differences in clearance efficacy or in production of T. brucei-specific immunoglobulin M (IgM) and IgG antibodies. Trypanosome-mediated immunopathological features, such as lymph node-associated immunosuppression and lipopolysaccharide hypersensitivity, were found to be greatly reduced in infected TNF-alpha-/- mice. These results demonstrate that, during trypanosome infections, TNF-alpha is a key mediator involved in both parasitemia control and infection-associated pathology.  (+info)

Aggregation and distribution of strains in microparasites. (6/808)

Recent research has shown that many parasite populations are made up of a number of epidemiologically distinct strains or genotypes. The implications of strain structure or genetic diversity for parasite population dynamics are still uncertain, partly because there is no coherent framework for the interpretation of field data. Here, we present an analysis of four published data sets for vector-borne microparasite infections where strains or genotypes have been distinguished: serotypes of African horse sickness (AHS) in zebra; types of Nannomonas trypanosomes in tsetse flies; parasite-induced erythrocyte surface antigen (PIESA) based isolates of Plasmodium falciparum malaria in humans, and the merozoite surface protein 2 gene (MSP-2) alleles of P. falciparum in humans and in anopheline mosquitoes. For each data set we consider the distribution of strains or types among hosts and any pairwise associations between strains or types. Where host age data are available we also compare age-prevalence relationships and estimates of the force of infection. Multiple infections of hosts are common and for most data sets infections have an aggregated distribution among hosts with a tendency towards positive associations between certain strains or types. These patterns could result from interactions (facilitation) between strains or types, or they could reflect patterns of contact between hosts and vectors. We use a mathematical model to illustrate the impact of host-vector contact patterns, finding that even if contact is random there may still be significant aggregation in parasite distributions. This effect is enhanced if there is non-random contact or other heterogeneities between hosts, vectors or parasites. In practice, different strains or types also have different forces of infection. We anticipate that aggregated distributions and positive associations between microparasite strains or types will be extremely common.  (+info)

T-Cell responses during Trypanosoma brucei infections in mice deficient in inducible nitric oxide synthase. (7/808)

We have investigated the possibility that nitric oxide (NO) synthesis may affect the course of a trypanosome infection via T-cell responses using mice deficient in inducible NO synthase (iNOS). Parasitemia levels increased at the same rate in both iNOS-deficient homozygous and control heterozygous mice, and peak parasitemia values were the same in both groups. However, the heterozygous mice maintained higher parasitemia levels after the peak of an infection than the homozygous mice due to a decrease in the rate of clearance of parasites. In iNOS-deficient mice there was an increase in the numbers of total CD4(+) cells and activated (interleukin-2 receptor-expressing) CD4(+) cells in infected mice compared with the numbers in uninfected mice. Spleen cells from infected iNOS-deficient mice displayed increased proliferative responses and gamma interferon secretion when stimulated in vitro than those of control mice. These data suggest that NO production depresses T-helper 1-like responses generated during Trypanosoma brucei infections, thus promoting the survival of the parasite.  (+info)

A nucleoside transporter from Trypanosoma brucei involved in drug resistance. (8/808)

Drug resistance of pathogens is an increasing problem whose underlying mechanisms are not fully understood. Cellular uptake of the major drugs against Trypanosoma brucei spp., the causative agents of sleeping sickness, is thought to occur through an unusual, so far unidentified adenosine transporter. Saccharomyces cerevisiae was used in a functional screen to clone a gene (TbAT1) from Trypanosoma brucei brucei that encodes a nucleoside transporter. When expressed in yeast, TbAT1 enabled adenosine uptake and conferred susceptibility to melaminophenyl arsenicals. Drug-resistant trypanosomes harbor a defective TbAT1 variant. The molecular identification of the entry route of trypanocides opens the way to approaches for diagnosis and treatment of drug-resistant sleeping sickness.  (+info)

African trypanosomiasis, also known as sleeping sickness, is a vector-borne parasitic disease caused by the protozoan Trypanosoma brucei. It is transmitted to humans through the bite of an infected tsetse fly (Glossina spp.). The disease has two stages: an early hemolymphatic stage characterized by fever, swollen lymph nodes, and skin rashes; and a late neurological stage characterized by sleep disturbances, personality changes, and motor abnormalities. If left untreated, it can be fatal. The disease is endemic in sub-Saharan Africa, where an estimated 65 million people are at risk of infection.

Trypanosomiasis is a parasitic disease caused by various species of the protozoan genus Trypanosoma. It is transmitted through the bite of an infected tsetse fly (in African trypanosomiasis or sleeping sickness) or reduviid bug (in American trypanosomiasis or Chagas disease). The parasites enter the bloodstream and lymphatic system, causing symptoms such as fever, swollen lymph nodes, skin lesions, and muscle pain. Untreated, it can lead to severe neurological complications and death in both forms of the disease. Prevention measures include avoiding insect bites, using insect repellents, and sleeping under insecticide-treated bed nets.

Bovine trypanosomiasis, also known as Nagana, is a parasitic disease that affects cattle and other animals. It is caused by various species of the protozoan parasite Trypanosoma, which are transmitted through the bite of tsetse flies (Glossina spp.).

The disease is characterized by fever, anemia, weight loss, decreased milk production, abortion in pregnant animals, and eventually death if left untreated. The parasites invade the bloodstream and lymphatic system, causing damage to various organs and tissues.

Bovine trypanosomiasis is a major constraint to livestock production in sub-Saharan Africa, where it affects millions of animals and causes significant economic losses to farmers and pastoralists. Control measures include the use of trypanocidal drugs, insecticide-treated cattle, and the reduction or elimination of tsetse fly populations through various methods such as trapping and habitat modification.

Trypanosoma brucei gambiense is a species of protozoan flagellate parasite that causes Human African Trypanosomiasis, also known as sleeping sickness. It is transmitted to humans through the bite of an infected tsetse fly (Glossina spp.). The parasite multiplies in various body fluids, including blood and cerebrospinal fluid, leading to a range of symptoms such as fever, headache, joint pain, and eventually severe neurological disorders if left untreated. T. b. gambiense is responsible for the majority of reported cases in West and Central Africa and is considered to be an anthroponosis, meaning it primarily infects humans.

Trypanocidal agents are a type of medication specifically used for the treatment and prevention of trypanosomiasis, which is a group of diseases caused by various species of protozoan parasites belonging to the genus Trypanosoma. These agents work by killing or inhibiting the growth of the parasites in the human body.

There are two main types of human trypanosomiasis: African trypanosomiasis, also known as sleeping sickness, which is caused by Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense; and American trypanosomiasis, also known as Chagas disease, which is caused by Trypanosoma cruzi.

Trypanocidal agents can be divided into two categories:

1. Drugs used to treat African trypanosomiasis: These include pentamidine, suramin, melarsoprol, and eflornithine. Pentamidine and suramin are used for the early stages of the disease, while melarsoprol and eflornithine are used for the later stages.
2. Drugs used to treat American trypanosomiasis: The main drug used for Chagas disease is benznidazole, which is effective in killing the parasites during the acute phase of the infection. Another drug, nifurtimox, can also be used, although it has more side effects than benznidazole.

It's important to note that trypanocidal agents have limited availability and are often associated with significant toxicity, making their use challenging in some settings. Therefore, prevention measures such as avoiding insect vectors and using vector control methods remain crucial in controlling the spread of these diseases.

Melarsoprol is an arsenic-based medication that is primarily used to treat the later stages of African trypanosomiasis, also known as sleeping sickness. It works by inhibiting the enzyme involved in energy metabolism of the parasite causing the disease, leading to its death. However, melarsoprol has a significant risk of serious side effects, including encephalopathy, which can be fatal. Therefore, it is typically used as a last resort when other treatments have failed or are not available. It is administered by intravenous injection in a hospital setting under close medical supervision.

Trypanosoma brucei rhodesiense is a species of protozoan parasite that causes African trypanosomiasis, also known as sleeping sickness, in humans. It is transmitted through the bite of an infected tsetse fly and is endemic to certain regions of East and Southern Africa.

The life cycle of T. b. rhodesiense involves two hosts: the tsetse fly and a mammalian host (such as a human). In the tsetse fly, the parasite undergoes development and multiplication in the midgut, then migrates to the salivary glands where it transforms into the metacyclic trypomastigote stage. When the infected tsetse fly bites a mammalian host, the metacyclic trypomastigotes are injected into the skin and enter the lymphatic system and bloodstream, where they multiply by binary fission as bloodstream trypomastigotes.

The symptoms of African trypanosomiasis caused by T. b. rhodesiense include fever, headache, joint pain, and itching, which may progress to more severe symptoms such as sleep disturbances, confusion, and neurological disorders if left untreated. The disease can be fatal if not diagnosed and treated promptly.

It is important to note that T. b. rhodesiense is distinct from another subspecies of Trypanosoma brucei called T. b. gambiense, which causes a different form of African trypanosomiasis that is endemic to West and Central Africa.

Trypanosoma brucei brucei is a species of protozoan flagellate parasite that causes African trypanosomiasis, also known as sleeping sickness in humans and Nagana in animals. This parasite is transmitted through the bite of an infected tsetse fly (Glossina spp.). The life cycle of T. b. brucei involves two main stages: the insect-dwelling procyclic trypomastigote stage and the mammalian-dwelling bloodstream trypomastigote stage.

The distinguishing feature of T. b. brucei is its ability to change its surface coat, which helps it evade the host's immune system. This allows the parasite to establish a long-term infection in the mammalian host. However, T. b. brucei is not infectious to humans; instead, two other subspecies, Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense, are responsible for human African trypanosomiasis.

In summary, Trypanosoma brucei brucei is a non-human-infective subspecies of the parasite that causes African trypanosomiasis in animals and serves as an essential model organism for understanding the biology and pathogenesis of related human-infective trypanosomes.

Trypanosoma is a genus of flagellated protozoan parasites belonging to the family Trypanosomatidae. These microscopic single-celled organisms are known to cause various tropical diseases in humans and animals, including Chagas disease (caused by Trypanosoma cruzi) and African sleeping sickness (caused by Trypanosoma brucei).

The life cycle of Trypanosoma involves alternating between an insect vector (like a tsetse fly or kissing bug) and a mammalian host. The parasites undergo complex morphological changes as they move through the different hosts and developmental stages, often exhibiting distinct forms in the insect vector compared to the mammalian host.

Trypanosoma species have an undulating membrane and a single flagellum that helps them move through their environment. They can be transmitted through various routes, including insect vectors, contaminated food or water, or congenital transmission from mother to offspring. The diseases caused by these parasites can lead to severe health complications and may even be fatal if left untreated.

Tsetse flies are not a medical condition but rather insects that can transmit diseases. Here is their medical relevance:

Tsetse flies (Glossina spp.) are large, biting flies found primarily in tropical Africa. They are vectors for African trypanosomiasis, also known as sleeping sickness in humans and Nagana in animals. The fly ingests the parasite when it takes a blood meal from an infected host, then transmits the disease to another host through its saliva during subsequent feedings. This makes tsetse flies medically relevant due to their role in spreading these diseases.

Trypanosoma congolense is a species of protozoan parasite that belongs to the genus Trypanosoma. It is the primary causative agent of African animal trypanosomiasis (AAT), also known as Nagana, which affects both wild and domestic animals in sub-Saharan Africa.

The life cycle of T. congolense involves two main hosts: the tsetse fly (Glossina spp.) and a mammalian host, such as cattle, sheep, goats, or wild animals. The parasite is transmitted to the mammalian host through the bite of an infected tsetse fly. Once inside the host's body, T. congolense multiplies in various bodily fluids, including blood, lymph, and cerebrospinal fluid, causing a range of symptoms such as fever, anemia, weight loss, and weakness.

In severe cases, AAT can lead to death, particularly in young or debilitated animals. The disease has significant economic impacts on agriculture and livestock production in affected regions, making it a major public health concern.

African Americans are defined as individuals who have ancestry from any of the black racial groups of Africa. This term is often used to describe people living in the United States who have total or partial descent from enslaved African peoples. The term does not refer to a single ethnicity but is a broad term that includes various ethnic groups with diverse cultures, languages, and traditions. It's important to note that some individuals may prefer to identify as Black or of African descent rather than African American, depending on their personal identity and background.

Trypanosoma vivax is a species of protozoan parasite that causes the disease surra in horses, mules, and donkeys, as well as other animals such as camels, dogs, and cats. It belongs to the family Trypanosomatidae and the order Kinetoplastida.

The parasite is transmitted through the bite of infected tsetse flies (Glossina spp.) and occurs in parts of Africa and Asia. The parasites multiply in the bloodstream and lymphatic system of the host, causing symptoms such as fever, anemia, weakness, and edema.

In advanced stages, surra can lead to severe neurological signs, coma, and death if left untreated. Diagnosis is typically made through microscopic examination of blood or tissue samples, and treatment involves the use of drugs such as diminazene accurate or suramin. Prevention measures include avoiding exposure to tsetse flies and using insect repellents or protective clothing.

The Democratic Republic of the Congo (DRC) is a country located in Central Africa. It is named after the Congo River, which flows through the country. The DRC is the second-largest country in Africa by area and the eleventh-largest in the world. It is home to a diverse population of more than 80 million people, making it one of the most populous countries on the continent.

The DRC is a democratic republic, which means that it is a form of government in which the people have the power to choose their leaders through free and fair elections. The country has a presidential system of government, in which the president serves as both the head of state and the head of government. The current president of the DRC is Félix Tshisekedi, who took office in January 2019.

The DRC is a federal republic, meaning that it is divided into several provinces, each with its own elected government. The country has a total of 26 provinces, which are further divided into districts and sectors.

The DRC is a member of various international organizations, including the United Nations, the African Union, and the Southern African Development Community. It is also a party to several international treaties and agreements, such as the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) and the Paris Agreement on climate change.

The DRC has a mixed economy, with both private and public sectors playing important roles. The country is rich in natural resources, including minerals such as copper, diamonds, gold, and tin. It also has large areas of fertile land that are suitable for agriculture. However, the DRC faces significant challenges, including poverty, corruption, and conflict. Despite these challenges, the country has made progress in recent years in terms of economic growth and development.

I'm not aware of any medical definitions associated with the term "Angola." Angola is a country located in Southern Africa, known officially as the Republic of Angola. It does not have any specific relevance to medical terminology or healthcare. If you have more context or information about why you are looking for a medical definition of Angola, I may be able to provide a more helpful response.

Pentamidine is an antimicrobial drug that is primarily used to treat and prevent certain types of pneumonia caused by the parasitic organisms Pneumocystis jirovecii (formerly known as P. carinii) and Leishmania donovani. It can also be used for the treatment of some fungal infections caused by Histoplasma capsulatum and Cryptococcus neoformans.

Pentamidine works by interfering with the DNA replication and protein synthesis of these microorganisms, which ultimately leads to their death. It is available as an injection or inhaled powder for medical use. Common side effects of pentamidine include nausea, vomiting, diarrhea, abdominal pain, and changes in blood sugar levels. More serious side effects can include kidney damage, hearing loss, and heart rhythm disturbances.

It is important to note that the use of pentamidine should be under the supervision of a healthcare professional due to its potential for serious side effects and drug interactions.

I'm not aware of any medical definitions associated with the term "Congo." The term "Congo" is most commonly used to refer to:

1. The Congo River, which is the second longest river in Africa, flowing through the Democratic Republic of the Congo and the Republic of the Congo.
2. The two countries located in Central Africa that share the name "Congo": the Democratic Republic of the Congo (formerly known as Zaire) and the Republic of the Congo (formerly known as French Congo or Middle Congo).
3. In historical contexts, "Congo" may also refer to the Congo Free State (1885-1908), a private colony of King Leopold II of Belgium, which later became the Belgian Congo (1908-1960) and then Zaire (1971-1997).

If you are looking for medical information or definitions related to tropical diseases, healthcare in Africa, or similar topics, I would recommend using more specific terms.

Central nervous system (CNS) protozoal infections refer to diseases caused by protozoa that invade and infect the brain and spinal cord. These infections can lead to serious neurological symptoms and complications.

There are several types of protozoa that can cause CNS infections, including:

1. Toxoplasma gondii: This parasite is commonly found in cats and can be transmitted to humans through contact with infected cat feces or consumption of undercooked meat. In people with weakened immune systems, T. gondii can cause severe CNS symptoms such as seizures, confusion, and coma.
2. Naegleria fowleri: Also known as the "brain-eating amoeba," N. fowleri is a free-living protozoan found in warm freshwater environments. When people swim or dive in infected water, the amoeba can enter the body through the nose and travel to the brain, causing primary amoebic meningoencephalitis (PAM), a rare but often fatal CNS infection.
3. Acanthamoeba: Like N. fowleri, Acanthamoeba is a free-living protozoan found in freshwater and soil. It can cause a range of CNS infections, including granulomatous amoebic encephalitis (GAE), which typically affects people with weakened immune systems.
4. Trypanosoma brucei: This parasite is transmitted through the bite of infected tsetse flies and causes African sleeping sickness, a CNS infection that can lead to coma and death if left untreated.
5. Plasmodium falciparum: While not strictly a protozoan, P. falciparum is a parasite that causes malaria, a mosquito-borne disease that can cause severe CNS symptoms such as seizures, coma, and cerebral malaria.

Treatment for CNS protozoal infections depends on the specific type of infection and may include antiprotozoal medications, antibiotics, or supportive care to manage symptoms. Prevention measures include avoiding contact with infected animals or insects, practicing good hygiene, and using appropriate protective measures such as insect repellent or bed nets in areas where these infections are common.

The Central African Republic (CAR) is a country located in the central region of Africa. It is not a medical term, but a geographical and political designation for a nation that has its own government, healthcare system, and public health challenges.

The CAR faces significant health issues, including a high burden of infectious diseases such as malaria, HIV/AIDS, tuberculosis, and neglected tropical diseases. Access to healthcare services is limited, particularly in rural areas, and the country has one of the lowest life expectancies in the world. Political instability and conflict have further exacerbated the health challenges in the CAR, leading to displacement, malnutrition, and reduced access to healthcare for many of its citizens.

Nifurtimox is an antiprotozoal medication used in the treatment of acute and chronic stages of American trypanosomiasis (Chagas disease) caused by Trypanosoma cruzi. It works by inhibiting the parasite's energy metabolism, ultimately leading to its death. Nifurtimox is often given orally in the form of tablets and its use is typically accompanied by close medical supervision due to potential side effects such as anorexia, nausea, vomiting, and neurological symptoms.

Eflornithine is a antiprotozoal medication, which is used to treat sleeping sickness (human African trypanosomiasis) caused by Trypanosoma brucei gambiense in adults and children. It works by inhibiting the enzyme ornithine decarboxylase, which is needed for the growth of the parasite. By doing so, it helps to control the infection and prevent further complications.

Eflornithine is also used as a topical cream to slow down excessive hair growth in women due to a condition called hirsutism. It works by interfering with the growth of hair follicles.

It's important to note that Eflornithine should be used under the supervision of a healthcare professional, and it may have side effects or interactions with other medications.

I'm sorry for any confusion, but "Sudan" is not a medical term. It is a country located in Northeast Africa, known as the Sudan or Sudan proper, and the southern region that seceded to become South Sudan in 2011. If you have any medical terms you would like me to define, please let me know!

Antiprotozoal agents are a type of medication used to treat protozoal infections, which are infections caused by microscopic single-celled organisms called protozoa. These agents work by either killing the protozoa or inhibiting their growth and reproduction. They can be administered through various routes, including oral, topical, and intravenous, depending on the type of infection and the severity of the illness.

Examples of antiprotozoal agents include:

* Metronidazole, tinidazole, and nitazoxanide for treating infections caused by Giardia lamblia and Entamoeba histolytica.
* Atovaquone, clindamycin, and pyrimethamine-sulfadoxine for treating malaria caused by Plasmodium falciparum or other Plasmodium species.
* Pentamidine and suramin for treating African trypanosomiasis (sleeping sickness) caused by Trypanosoma brucei gambiense or T. b. rhodesiense.
* Nitroimidazoles, such as benznidazole and nifurtimox, for treating Chagas disease caused by Trypanosoma cruzi.
* Sodium stibogluconate and paromomycin for treating leishmaniasis caused by Leishmania species.

Antiprotozoal agents can have side effects, ranging from mild to severe, depending on the drug and the individual patient's response. It is essential to follow the prescribing physician's instructions carefully when taking these medications and report any adverse reactions promptly.

'Insect control' is not a term typically used in medical definitions. However, it generally refers to the methods and practices used to manage or reduce the population of insects that can be harmful or disruptive to human health, food supply, or property. This can include various strategies such as chemical pesticides, biological control agents, habitat modification, and other integrated pest management techniques.

In medical terms, 'vector control' is a more relevant concept, which refers to the specific practices used to reduce or prevent the transmission of infectious diseases by insects and other arthropods that act as disease vectors (such as mosquitoes, ticks, and fleas). Vector control measures may include the use of insecticides, larvicides, biological control agents, environmental management, personal protection methods, and other integrated vector management strategies.

I'm sorry for any confusion, but the term "Africa" actually refers to a continent, not a medical condition or concept. Africa is the second-largest continent in the world, consisting of 54 countries and a wide range of diverse ethnic groups, cultures, languages, and landscapes. It is home to a vast array of wildlife, including many species that are not found anywhere else in the world. If you have any questions about Africa's geography, history, or culture, I would be happy to try to help answer them!

Chagas disease, also known as American trypanosomiasis, is a tropical parasitic disease caused by the protozoan *Trypanosoma cruzi*. It is primarily transmitted to humans through the feces of triatomine bugs (also called "kissing bugs"), which defecate on the skin of people while they are sleeping. The disease can also be spread through contaminated food or drink, during blood transfusions, from mother to baby during pregnancy or childbirth, and through organ transplantation.

The acute phase of Chagas disease can cause symptoms such as fever, fatigue, body aches, headache, rash, loss of appetite, diarrhea, and vomiting. However, many people do not experience any symptoms during the acute phase. After several weeks or months, most people enter the chronic phase of the disease, which can last for decades or even a lifetime. During this phase, many people do not have any symptoms, but about 20-30% of infected individuals will develop serious cardiac or digestive complications, such as heart failure, arrhythmias, or difficulty swallowing.

Chagas disease is primarily found in Latin America, where it is estimated that around 6-7 million people are infected with the parasite. However, due to increased travel and migration, cases of Chagas disease have been reported in other parts of the world, including North America, Europe, and Asia. There is no vaccine for Chagas disease, but medications are available to treat the infection during the acute phase and to manage symptoms during the chronic phase.

The term "African Continental Ancestry Group" is a racial category used in the field of genetics and population health to describe individuals who have ancestral origins in the African continent. This group includes people from diverse ethnic backgrounds, cultures, and languages across the African continent. It's important to note that this term is used for genetic and epidemiological research purposes and should not be used to make assumptions about an individual's personal identity, culture, or experiences.

It's also worth noting that there is significant genetic diversity within Africa, and using a single category to describe all individuals with African ancestry can oversimplify this diversity. Therefore, it's more accurate and informative to specify the particular population or region of African ancestry when discussing genetic research or health outcomes.

Central Africa is a geographical region that broadly includes the countries that lie near the equator and are found in the interior of the African continent. The United Nations defines Central Africa as consisting of the following countries: Angola, Burundi, Cameroon, Central African Republic, Chad, Democratic Republic of the Congo, Republic of the Congo, Equatorial Guinea, Gabon, Rwanda, and Sao Tome and Principe.

The region is characterized by diverse cultures, languages, and landscapes, ranging from dense rainforests to vast savannas. Central Africa is home to many important rivers, including the Congo River, which is the second longest river in Africa and the deepest river in the world. The region also contains numerous national parks and wildlife reserves that protect a diverse array of plant and animal species, including several endangered species such as mountain gorillas, chimpanzees, and forest elephants.

Central Africa faces many challenges, including political instability, poverty, and environmental degradation. The region has been plagued by conflicts and civil wars, which have resulted in significant loss of life, displacement of people, and destruction of infrastructure. Climate change and deforestation are also major concerns, as they threaten the region's biodiversity and contribute to global warming.

In terms of healthcare, Central Africa faces many challenges, including a high burden of infectious diseases such as HIV/AIDS, malaria, tuberculosis, and Ebola. Access to healthcare is limited in many areas, particularly in rural communities, and there is a shortage of healthcare workers and medical facilities. In addition, the region has been affected by conflicts and humanitarian crises, which have further strained healthcare systems and made it difficult to provide adequate care to those in need.

Trypanosoma cruzi is a protozoan parasite that causes Chagas disease, also known as American trypanosomiasis. It's transmitted to humans and other mammals through the feces of triatomine bugs, often called "kissing bugs." The parasite can also be spread through contaminated food, drink, or from mother to baby during pregnancy or birth.

The life cycle of Trypanosoma cruzi involves two main forms: the infective metacyclic trypomastigote that is found in the bug's feces and the replicative intracellular amastigote that resides within host cells. The metacyclic trypomastigotes enter the host through mucous membranes or skin lesions, where they invade various types of cells and differentiate into amastigotes. These amastigotes multiply by binary fission and then differentiate back into trypomastigotes, which are released into the bloodstream when the host cell ruptures. The circulating trypomastigotes can then infect other cells or be taken up by another triatomine bug during a blood meal, continuing the life cycle.

Clinical manifestations of Chagas disease range from an acute phase with non-specific symptoms like fever, swelling, and fatigue to a chronic phase characterized by cardiac and gastrointestinal complications, which can develop decades after the initial infection. Early detection and treatment of Chagas disease are crucial for preventing long-term health consequences.

Suramin is a medication that has been used for the treatment of African sleeping sickness, which is caused by trypanosomes. It works as a reverse-specific protein kinase CK inhibitor and also blocks the attachment of the parasite to the host cells. Suramin is not absorbed well from the gastrointestinal tract and is administered intravenously.

It should be noted that Suramin is an experimental treatment for other conditions such as cancer, neurodegenerative diseases, viral infections and autoimmune diseases, but it's still under investigation and has not been approved by FDA for those uses.

Diminazene is an antiparasitic drug, primarily used in veterinary medicine to treat and prevent infections caused by trypanosomes, which are protozoan parasites that can affect both animals and humans. The drug works by inhibiting the protein synthesis of the parasite, leading to its death.

In human medicine, diminazene is used as an alternative treatment for acute African trypanosomiasis (sleeping sickness) caused by Trypanosoma brucei gambiense in areas where other treatments are not available or have failed. It is usually given by intramuscular injection and is often used in combination with suramin.

It's important to note that the use of diminazene in human medicine is limited due to its potential toxicity, and it should only be administered under the supervision of a healthcare professional.

I'm sorry for any confusion, but "Uganda" is not a medical term or concept. It is the name of a country located in East Africa, known officially as the Republic of Uganda. If you have any questions about medical terms or concepts, I would be happy to help with those!

Benzamidines are a group of organic compounds that contain a benzene ring linked to an amidine functional group. They are commonly used as antimicrobial agents, particularly in the treatment of various gram-negative bacterial infections. Benzamidines work by inhibiting the enzyme bacterial dehydrogenases, which are essential for the bacteria's survival.

Some examples of benzamidine derivatives include:

* Tempanamine hydrochloride (Tembaglanil): used to treat urinary tract infections caused by susceptible strains of Escherichia coli and Klebsiella pneumoniae.
* Chlorhexidine: a broad-spectrum antimicrobial agent used as a disinfectant and preservative in various medical and dental applications.
* Prothiobenzamide: an anti-inflammatory and analgesic drug used to treat gout and rheumatoid arthritis.

It is important to note that benzamidines have a narrow therapeutic index, which means that the difference between an effective dose and a toxic dose is small. Therefore, they should be used with caution and under the supervision of a healthcare professional.

Neglected Tropical Diseases (NTDs) are a group of infectious diseases that primarily affect people living in poverty, in tropical and subtropical areas. These diseases are called "neglected" because they have been largely ignored by medical research and drug development, as well as by global health agencies and pharmaceutical companies.

The World Health Organization (WHO) has identified 20 diseases as NTDs, including:

1. Buruli ulcer
2. Chagas disease
3. Dengue and chikungunya
4. Dracunculiasis (guinea-worm disease)
5. Echinococcosis
6. Endemic treponematoses
7. Foodborne trematodiases
8. Human African trypanosomiasis (sleeping sickness)
9. Leishmaniasis
10. Leprosy (Hansen's disease)
11. Lymphatic filariasis
12. Onchocerciasis (river blindness)
13. Rabies
14. Schistosomiasis
15. Soil-transmitted helminthiases
16. Snakebite envenoming
17. Taeniasis/Cysticercosis
18. Trachoma
19. Mycetoma, chromoblastomycosis and other deep mycoses
20. Yaws (Endemic treponematoses)

These diseases can lead to severe disfigurement, disability, and even death if left untreated. They affect more than 1 billion people worldwide, mainly in low-income countries in Africa, Asia, and the Americas. NTDs also have significant social and economic impacts, contributing to poverty, stigma, discrimination, and exclusion.

Efforts are underway to raise awareness and increase funding for research, prevention, and treatment of NTDs. The WHO has set targets for controlling or eliminating several NTDs by 2030, including dracunculiasis, lymphatic filariasis, onchocerciasis, trachoma, and human African trypanosomiasis.

Variants surface glycoproteins (VSGs) in Trypanosoma are a group of molecules found on the surface of the parasitic protozoan that causes African trypanosomiasis, also known as sleeping sickness. These proteins play a crucial role in the survival of the parasite within the host's body by allowing it to evade the host's immune system.

Trypanosoma parasites have a single VSG gene that is actively expressed at any given time, while thousands of other VSG genes remain silent. The expressed VSG protein is located on the surface of the parasite and serves as a target for the host's immune response. However, when the host's immune system produces antibodies against the VSG protein, the parasite undergoes a process called "antigenic variation" where it switches to expressing a different VSG gene, allowing it to evade the immune response.

This continuous switching of VSG genes allows the parasite to avoid clearance by the host's immune system and establish a chronic infection. Understanding the mechanisms of antigenic variation and VSG gene regulation is important for developing new strategies for treating African trypanosomiasis.

Parasitic sensitivity tests, also known as parasite drug susceptibility tests, refer to laboratory methods used to determine the effectiveness of specific antiparasitic medications against a particular parasitic infection. These tests help healthcare providers identify which drugs are most likely to be effective in treating an individual's infection and which ones should be avoided due to resistance or increased risk of side effects.

There are several types of parasitic sensitivity tests, including:

1. In vitro susceptibility testing: This involves culturing the parasite in a laboratory setting and exposing it to different concentrations of antiparasitic drugs. The growth or survival of the parasite is then observed and compared to a control group that was not exposed to the drug. This helps identify the minimum inhibitory concentration (MIC) of the drug, which is the lowest concentration required to prevent the growth of the parasite.
2. Molecular testing: This involves analyzing the genetic material of the parasite to detect specific mutations or gene variations that are associated with resistance to certain antiparasitic drugs. This type of testing can be performed using a variety of methods, including polymerase chain reaction (PCR) and DNA sequencing.
3. Phenotypic testing: This involves observing the effects of antiparasitic drugs on the growth or survival of the parasite in a laboratory setting. For example, a parasite may be grown in a culture medium and then exposed to different concentrations of a drug. The growth of the parasite is then monitored over time to determine the drug's effectiveness.

Parasitic sensitivity tests are important for guiding the treatment of many parasitic infections, including malaria, tuberculosis, and leishmaniasis. These tests can help healthcare providers choose the most effective antiparasitic drugs for their patients, reduce the risk of drug resistance, and improve treatment outcomes.

Parasitology is a branch of biology that deals with the study of parasites, their life cycles, the relationship between parasites and their hosts, the transmission of parasitic diseases, and the development of methods for their control and elimination. It involves understanding various types of parasites including protozoa, helminths, and arthropods that can infect humans, animals, and plants. Parasitologists also study the evolution, genetics, biochemistry, and ecology of parasites to develop effective strategies for their diagnosis, treatment, and prevention.

Antibodies, protozoan, refer to the immune system's response to an infection caused by a protozoan organism. Protozoa are single-celled microorganisms that can cause various diseases in humans, such as malaria, giardiasis, and toxoplasmosis.

When the body is infected with a protozoan, the immune system responds by producing specific proteins called antibodies. Antibodies are produced by a type of white blood cell called a B-cell, and they recognize and bind to specific antigens on the surface of the protozoan organism.

There are five main types of antibodies: IgA, IgD, IgE, IgG, and IgM. Each type of antibody has a different role in the immune response. For example, IgG is the most common type of antibody and provides long-term immunity to previously encountered pathogens. IgM is the first antibody produced in response to an infection and is important for activating the complement system, which helps to destroy the protozoan organism.

Overall, the production of antibodies against protozoan organisms is a critical part of the immune response and helps to protect the body from further infection.

Agglutination tests are laboratory diagnostic procedures used to detect the presence of antibodies or antigens in a sample, such as blood or serum. These tests work by observing the clumping (agglutination) of particles, like red blood cells or bacteriophages, coated with specific antigens or antibodies when mixed with a patient's sample.

In an agglutination test, the sample is typically combined with a reagent containing known antigens or antibodies on the surface of particles, such as latex beads, red blood cells, or bacteriophages. If the sample contains the corresponding antibodies or antigens, they will bind to the particles, forming visible clumps or agglutinates. The presence and strength of agglutination are then assessed visually or with automated equipment to determine the presence and quantity of the target antigen or antibody in the sample.

Agglutination tests are widely used in medical diagnostics for various applications, including:

1. Bacterial and viral infections: To identify specific bacterial or viral antigens in a patient's sample, such as group A Streptococcus, Legionella pneumophila, or HIV.
2. Blood typing: To determine the ABO blood group and Rh type of a donor or recipient before a blood transfusion or organ transplantation.
3. Autoimmune diseases: To detect autoantibodies in patients with suspected autoimmune disorders, such as rheumatoid arthritis, systemic lupus erythematosus, or Hashimoto's thyroiditis.
4. Allergies: To identify specific IgE antibodies in a patient's sample to determine allergic reactions to various substances, such as pollen, food, or venom.
5. Drug monitoring: To detect and quantify the presence of drug-induced antibodies, such as those developed in response to penicillin or hydralazine therapy.

Agglutination tests are simple, rapid, and cost-effective diagnostic tools that provide valuable information for clinical decision-making and patient management. However, they may have limitations, including potential cross-reactivity with other antigens, false-positive results due to rheumatoid factors or heterophile antibodies, and false-negative results due to the prozone effect or insufficient sensitivity. Therefore, it is essential to interpret agglutination test results in conjunction with clinical findings and other laboratory data.

To the best of my knowledge, "Côte d'Ivoire" is not a medical term or concept. It is the name of a country, which is officially known as the Republic of Côte d'Ivoire. The country is located in West Africa and is bordered by countries such as Ghana, Mali, Burkina Faso, and Liberia.

Côte d'Ivoire was once a French colony and gained its independence in 1960. The country has a diverse population and a developing economy, with agriculture being a major contributor to its GDP. The capital city of Côte d'Ivoire is Yamoussoukro, while the largest city is Abidjan.

It's important to note that medical terminology and concepts are typically related to anatomy, physiology, diseases, treatments, and other health-related topics. Therefore, it's unlikely that a country name like Côte d'Ivoire would have a direct medical definition or application.

Insect vectors are insects that transmit disease-causing pathogens (such as viruses, bacteria, parasites) from one host to another. They do this while feeding on the host's blood or tissues. The insects themselves are not infected by the pathogen but act as mechanical carriers that pass it on during their bite. Examples of diseases spread by insect vectors include malaria (transmitted by mosquitoes), Lyme disease (transmitted by ticks), and plague (transmitted by fleas). Proper prevention measures, such as using insect repellent and reducing standing water where mosquitoes breed, can help reduce the risk of contracting these diseases.

I'm sorry for any confusion, but "Zambia" is not a medical term. It is the name of a country located in southern Africa, known officially as the Republic of Zambia. If you have any questions related to medical terminology or health-related topics, I would be happy to help with those!

Tropical medicine is a branch of medicine that deals with health problems that are prevalent in or unique to tropical and subtropical regions. These regions are typically characterized by hot and humid climates, and often have distinct ecological systems that can contribute to the spread of infectious diseases.

The field of tropical medicine encompasses a wide range of health issues, including:

1. Infectious diseases: Many tropical diseases are caused by infectious agents such as bacteria, viruses, parasites, and fungi. Some of the most common infectious diseases in the tropics include malaria, dengue fever, yellow fever, chikungunya, Zika virus, leishmaniasis, schistosomiasis, and Chagas disease.
2. Neglected tropical diseases (NTDs): A group of chronic infectious diseases that primarily affect poor and marginalized populations in the tropics. NTDs include diseases such as human African trypanosomiasis (sleeping sickness), leprosy, Buruli ulcer, and dracunculiasis (guinea worm disease).
3. Zoonotic diseases: Diseases that are transmitted between animals and humans, often through insect vectors or contaminated food and water. Examples of zoonotic diseases in the tropics include rabies, leptospirosis, and Rift Valley fever.
4. Environmental health issues: The tropical environment can pose unique health challenges, such as exposure to toxic chemicals, heat stress, and poor air quality. Tropical medicine also addresses these environmental health issues.
5. Travel medicine: As global travel increases, there is a growing need for medical professionals who are knowledgeable about the health risks associated with traveling to tropical destinations. Tropical medicine physicians often provide pre-travel consultations and post-travel evaluations for international travelers.

Overall, tropical medicine is an essential field that addresses the unique health challenges faced by populations living in or traveling to tropical and subtropical regions.

Cerebrospinal fluid (CSF) is a clear, colorless fluid that surrounds and protects the brain and spinal cord. It acts as a shock absorber for the central nervous system and provides nutrients to the brain while removing waste products. CSF is produced by specialized cells called ependymal cells in the choroid plexus of the ventricles (fluid-filled spaces) inside the brain. From there, it circulates through the ventricular system and around the outside of the brain and spinal cord before being absorbed back into the bloodstream. CSF analysis is an important diagnostic tool for various neurological conditions, including infections, inflammation, and cancer.

Leishmaniasis is a complex of diseases caused by the protozoan parasites of the Leishmania species, which are transmitted to humans through the bite of infected female phlebotomine sandflies. The disease presents with a variety of clinical manifestations, depending upon the Leishmania species involved and the host's immune response.

There are three main forms of leishmaniasis: cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral leishmaniasis (VL), also known as kala-azar. CL typically presents with skin ulcers, while MCL is characterized by the destruction of mucous membranes in the nose, mouth, and throat. VL, the most severe form, affects internal organs such as the spleen, liver, and bone marrow, causing symptoms like fever, weight loss, anemia, and enlarged liver and spleen.

Leishmaniasis is prevalent in many tropical and subtropical regions, including parts of Asia, Africa, South America, and southern Europe. The prevention strategies include using insect repellents, wearing protective clothing, and improving housing conditions to minimize exposure to sandflies. Effective treatment options are available for leishmaniasis, depending on the form and severity of the disease, geographical location, and the Leishmania species involved.

A disease vector is a living organism that transmits infectious pathogens from one host to another. These vectors can include mosquitoes, ticks, fleas, and other arthropods that carry viruses, bacteria, parasites, or other disease-causing agents. The vector becomes infected with the pathogen after biting an infected host, and then transmits the infection to another host through its saliva or feces during a subsequent blood meal.

Disease vectors are of particular concern in public health because they can spread diseases rapidly and efficiently, often over large geographic areas. Controlling vector-borne diseases requires a multifaceted approach that includes reducing vector populations, preventing bites, and developing vaccines or treatments for the associated diseases.

There doesn't seem to be a specific medical definition for "DNA, protozoan" as it is simply a reference to the DNA found in protozoa. Protozoa are single-celled eukaryotic organisms that can be found in various environments such as soil, water, and the digestive tracts of animals.

Protozoan DNA refers to the genetic material present in these organisms. It is composed of nucleic acids, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), which contain the instructions for the development, growth, and reproduction of the protozoan.

The DNA in protozoa, like in other organisms, is made up of two strands of nucleotides that coil together to form a double helix. The four nucleotide bases that make up protozoan DNA are adenine (A), thymine (T), guanine (G), and cytosine (C). These bases pair with each other to form the rungs of the DNA ladder, with A always pairing with T and G always pairing with C.

The genetic information stored in protozoan DNA is encoded in the sequence of these nucleotide bases. This information is used to synthesize proteins, which are essential for the structure and function of the organism's cells. Protozoan DNA also contains other types of genetic material, such as regulatory sequences that control gene expression and repetitive elements with no known function.

Understanding the DNA of protozoa is important for studying their biology, evolution, and pathogenicity. It can help researchers develop new treatments for protozoan diseases and gain insights into the fundamental principles of genetics and cellular function.

Flocculation tests are diagnostic procedures used in medical laboratories to detect and measure the presence of certain substances, such as proteins or bacteria, in a sample. These tests work by adding a reagent to the sample that causes any targeted substances to clump together (flocculate) and become visible or easily measurable.

For example, in a coagulation or flocculation test for proteinuria (protein in urine), a reagent such as sulfosalicylic acid is added to a urine sample. If proteins are present in the sample, they will react with the reagent and form a white precipitate that can be seen with the naked eye or measured with a spectrophotometer.

Flocculation tests are commonly used in clinical chemistry and microbiology to diagnose various medical conditions, monitor treatment progress, and assess overall health status.

I'm sorry for any confusion, but "Gabon" is not a medical term. It is the name of a country located in Central Africa, known officially as the Gabonese Republic. If you have any questions about medical terminology or health-related topics, I would be happy to help with those!

Nitroimidazoles are a class of antibiotic drugs that contain a nitro group (-NO2) attached to an imidazole ring. These medications have both antiprotozoal and antibacterial properties, making them effective against a range of anaerobic organisms, including bacteria and parasites. They work by being reduced within the organism, which leads to the formation of toxic radicals that interfere with DNA function and ultimately kill the microorganism.

Some common examples of nitroimidazoles include:

* Metronidazole: used for treating infections caused by anaerobic bacteria and protozoa, such as bacterial vaginosis, amebiasis, giardiasis, and pseudomembranous colitis.
* Tinidazole: similar to metronidazole, it is used to treat various infections caused by anaerobic bacteria and protozoa, including trichomoniasis, giardiasis, and amebiasis.
* Secnidazole: another medication in this class, used for the treatment of bacterial vaginosis, trichomoniasis, and amebiasis.

Nitroimidazoles are generally well-tolerated, but side effects can include gastrointestinal symptoms like nausea, vomiting, or diarrhea. Rare but serious side effects may include peripheral neuropathy (nerve damage) and central nervous system toxicity, particularly with high doses or long-term use. It is essential to follow the prescribed dosage and duration closely to minimize potential risks while ensuring effective treatment.

Central nervous system (CNS) parasitic infections refer to the invasion and infection of the brain and/or spinal cord by parasites. These infections can cause a range of symptoms depending on the type of parasite, the location of the infection within the CNS, and the severity of the infection.

Parasites that can infect the CNS include protozoa (such as Toxoplasma gondii, Naegleria fowleri, and Plasmodium falciparum), helminths (such as cysticercosis caused by Taenia solium tapeworm larvae), and arthropods (such as ticks that can transmit Lyme disease).

Symptoms of CNS parasitic infections can include headache, fever, seizures, confusion, weakness, numbness, loss of coordination, and changes in behavior or personality. Diagnosis typically involves a combination of clinical evaluation, imaging studies (such as MRI or CT scans), and laboratory tests (such as CSF analysis or PCR).

Treatment for CNS parasitic infections depends on the specific type of parasite involved and may include medications such as antiparasitics, antibiotics, or corticosteroids. In some cases, surgery may be necessary to remove parasites or cysts from the CNS. Prevention measures include avoiding contaminated food and water, practicing good hygiene, using insect repellent, and seeking prompt medical attention for any suspected infectious symptoms.

I'm sorry for any confusion, but "Protozoan Proteins" is not a specific medical or scientific term. Protozoa are single-celled eukaryotic organisms, and proteins are large biological molecules consisting of one or more chains of amino acid residues. Therefore, "Protozoan Proteins" generally refers to the various types of proteins found in protozoa.

However, if you're looking for information about proteins specific to certain protozoan parasites with medical relevance (such as Plasmodium falciparum, which causes malaria), I would be happy to help! Please provide more context or specify the particular protozoan of interest.

I'm sorry for any confusion, but "Guinea" is not a medical term. It is a geographical term referring to a region on the west coast of Africa, as well as the country of Equatorial Guinea and its neighboring countries. Additionally, "Guinea" can also refer to a unit of currency in Liberia.

If you have any medical concerns or questions, I would be happy to try to help answer them for you.

I apologize, but "Chad" is not a medical term or condition. It is a given name and also a slang term that has been used in popular culture to refer to an attractive man or a stereotypical fraternity member in some English-speaking countries. If you have any questions about medical terminology, I would be happy to help answer those for you.

"Africa South of the Sahara" is a term commonly used in medical and scientific literature to refer to the region of the African continent that lies south of the Sahara Desert. This region includes 48 countries, with a population of over 1 billion people, and is characterized by its tropical or subtropical climate, diverse cultures, and unique health challenges.

The term "South of the Sahara" is used to distinguish this region from North Africa, which is predominantly Arab and Berber in culture and has closer ties to the Middle East than to Sub-Saharan Africa. The Sahara Desert serves as a natural geographical boundary between these two regions.

In medical terms, "Africa South of the Sahara" encompasses a wide range of health issues, including infectious diseases such as HIV/AIDS, malaria, tuberculosis, and Ebola, which are prevalent in many parts of the region. The area also faces challenges related to maternal and child health, nutrition, water and sanitation, and non-communicable diseases such as cancer, diabetes, and cardiovascular disease.

Medical research and interventions focused on "Africa South of the Sahara" aim to address these unique health challenges and improve the overall health outcomes of the population in this region.

An endemic disease is a type of disease that is regularly found among particular people or in a certain population, and is spread easily from person to person. The rate of infection is consistently high in these populations, but it is relatively stable and does not change dramatically over time. Endemic diseases are contrasted with epidemic diseases, which suddenly increase in incidence and spread rapidly through a large population.

Endemic diseases are often associated with poverty, poor sanitation, and limited access to healthcare. They can also be influenced by environmental factors such as climate, water quality, and exposure to vectors like mosquitoes or ticks. Examples of endemic diseases include malaria in some tropical countries, tuberculosis (TB) in many parts of the world, and HIV/AIDS in certain populations.

Effective prevention and control measures for endemic diseases typically involve improving access to healthcare, promoting good hygiene and sanitation practices, providing vaccinations when available, and implementing vector control strategies. By addressing the underlying social and environmental factors that contribute to the spread of these diseases, it is possible to reduce their impact on affected populations and improve overall health outcomes.

African Swine Fever Virus (ASFV) is a large, double-stranded DNA virus that belongs to the Asfarviridae family. It is the causative agent of African swine fever (ASF), a highly contagious and deadly disease in domestic pigs and wild boars. The virus can be transmitted through direct contact with infected animals, contaminated feed, or fomites (inanimate objects).

ASFV infects cells of the monocyte-macrophage lineage and replicates in the cytoplasm of these cells. The virus causes a range of clinical signs, including fever, loss of appetite, hemorrhages, and death in severe cases. There is no effective vaccine or treatment available for ASF, and control measures rely on early detection, quarantine, and culling of infected animals to prevent the spread of the disease.

It's important to note that African swine fever virus is not a threat to human health, but it can have significant economic impacts on the pig industry due to high mortality rates in affected herds and trade restrictions imposed by countries to prevent the spread of the disease.

I apologize for any confusion, but "livestock" is not a term that has a medical definition. It is an agricultural term that refers to animals that are kept or raised on a farm or ranch for commercial purposes, such as the production of food, fiber, or labor. Examples of livestock include cattle, sheep, goats, pigs, poultry, and horses. I hope this clarifies any confusion. If you have any questions related to medical terminology, I would be happy to help.

I'm sorry for any confusion, but "South Africa" is not a medical term or concept. It is a country located at the southernmost tip of the African continent. If you have any questions related to medical topics, I would be happy to help answer them!

Parasitic diseases are infections or illnesses caused by parasites, which are organisms that live and feed on host organisms, often causing harm. Parasites can be protozoans (single-celled organisms), helminths (worms), or ectoparasites (ticks, mites, fleas). These diseases can affect various body systems and cause a range of symptoms, depending on the type of parasite and the location of infection. They are typically spread through contaminated food or water, insect vectors, or direct contact with an infected host or contaminated environment. Examples of parasitic diseases include malaria, giardiasis, toxoplasmosis, ascariasis, and leishmaniasis.

Protozoan infections are diseases caused by microscopic, single-celled organisms known as protozoa. These parasites can enter the human body through contaminated food, water, or contact with an infected person or animal. Once inside the body, they can multiply and cause a range of symptoms depending on the type of protozoan and where it infects in the body. Some common protozoan infections include malaria, giardiasis, amoebiasis, and toxoplasmosis. Symptoms can vary widely but may include diarrhea, abdominal pain, fever, fatigue, and skin rashes. Treatment typically involves the use of antiprotozoal medications to kill the parasites and alleviate symptoms.

Parasitemia is a medical term that refers to the presence of parasites, particularly malaria-causing Plasmodium species, in the bloodstream. It is the condition where red blood cells are infected by these parasites, which can lead to various symptoms such as fever, chills, anemia, and organ damage in severe cases. The level of parasitemia is often used to assess the severity of malaria infection and to guide treatment decisions.

A chancre is a medical term that refers to a hard, painless skin ulcer that is typically the first stage of certain bacterial infections, most commonly syphilis. It is usually round or oval in shape and can appear as a sore or lesion on the skin or mucous membranes, such as the genitals, anus, or mouth. The chancre is caused by the bacterium Treponema pallidum and is typically accompanied by swollen lymph nodes in the nearby area.

The chancre usually develops about 3 weeks after exposure to the bacteria and can last for several weeks. While it may heal on its own, it's important to seek medical attention if you suspect you have a chancre, as syphilis is a serious infection that can cause long-term health problems if left untreated. Treatment with antibiotics, such as penicillin, can cure syphilis and prevent further complications.

I'm sorry for any confusion, but "travel" is not a term that has a specific medical definition. In general, travel refers to the act of moving or journeying from one place to another, often over long distances. However, in a medical context, it might refer to the recommendation that individuals with certain medical conditions or those who are immunocompromised avoid traveling to areas where they may be at increased risk of exposure to infectious diseases. It's always best to check with a healthcare professional for advice related to specific medical situations and travel.

Amidines are organic compounds that contain a functional group with the structure R-C=N-R, where R can be an alkyl or aromatic group. This functional group consists of a carbonyl (C=O) group and a nitrogen atom (N) connected to two organic groups (R).

In medical terminology, amidines are not commonly used. However, some amidine derivatives have been investigated for their potential therapeutic properties. For example, certain amidine compounds have shown antimicrobial, anti-inflammatory, and antiviral activities. Some of these compounds have also been studied as potential drugs for the treatment of various diseases, including cancer, cardiovascular disease, and neurological disorders.

It is important to note that while some amidines may have therapeutic potential, they can also be toxic at high concentrations and should be handled with care.

Blood is the fluid that circulates in the body of living organisms, carrying oxygen and nutrients to the cells and removing carbon dioxide and other waste products. It is composed of red and white blood cells suspended in a liquid called plasma. The main function of blood is to transport oxygen from the lungs to the body's tissues and carbon dioxide from the tissues to the lungs. It also transports nutrients, hormones, and other substances to the cells and removes waste products from them. Additionally, blood plays a crucial role in the body's immune system by helping to fight infection and disease.

I'm sorry for any confusion, but "Tanzania" is not a medical term. It is the name of a country located in East Africa. If you have any questions about medical terms or conditions, I would be happy to help clarify those for you.

The term "European Continental Ancestry Group" is a medical/ethnic classification that refers to individuals who trace their genetic ancestry to the continent of Europe. This group includes people from various ethnic backgrounds and nationalities, such as Northern, Southern, Eastern, and Western European descent. It is often used in research and medical settings for population studies or to identify genetic patterns and predispositions to certain diseases that may be more common in specific ancestral groups. However, it's important to note that this classification can oversimplify the complex genetic diversity within and between populations, and should be used with caution.

Meningoencephalitis is a medical term that refers to an inflammation of both the brain (encephalitis) and the membranes covering the brain and spinal cord (meninges), known as the meninges. It is often caused by an infection, such as bacterial or viral infections, that spreads to the meninges and brain. In some cases, it can also be caused by other factors like autoimmune disorders or certain medications.

The symptoms of meningoencephalitis may include fever, headache, stiff neck, confusion, seizures, and changes in mental status. If left untreated, this condition can lead to serious complications, such as brain damage, hearing loss, learning disabilities, or even death. Treatment typically involves antibiotics for bacterial infections or antiviral medications for viral infections, along with supportive care to manage symptoms and prevent complications.

Antiparasitic agents are a type of medication used to treat parasitic infections. These agents include a wide range of drugs that work to destroy, inhibit the growth of, or otherwise eliminate parasites from the body. Parasites are organisms that live on or inside a host and derive nutrients at the host's expense.

Antiparasitic agents can be divided into several categories based on the type of parasite they target. Some examples include:

* Antimalarial agents: These drugs are used to treat and prevent malaria, which is caused by a parasite that is transmitted through the bites of infected mosquitoes.
* Antiprotozoal agents: These drugs are used to treat infections caused by protozoa, which are single-celled organisms that can cause diseases such as giardiasis, amoebic dysentery, and sleeping sickness.
* Antihelminthic agents: These drugs are used to treat infections caused by helminths, which are parasitic worms that can infect various organs of the body, including the intestines, lungs, and skin. Examples include roundworms, tapeworms, and flukes.

Antiparasitic agents work in different ways to target parasites. Some disrupt the parasite's metabolism or interfere with its ability to reproduce. Others damage the parasite's membrane or exoskeleton, leading to its death. The specific mechanism of action depends on the type of antiparasitic agent and the parasite it is targeting.

It is important to note that while antiparasitic agents can be effective in treating parasitic infections, they can also have side effects and potential risks. Therefore, it is essential to consult with a healthcare provider before starting any antiparasitic medication to ensure safe and appropriate use.

A disease reservoir refers to a population or group of living organisms, including humans, animals, and even plants, that can naturally carry and transmit a particular pathogen (disease-causing agent) without necessarily showing symptoms of the disease themselves. These hosts serve as a source of infection for other susceptible individuals, allowing the pathogen to persist and circulate within a community or environment.

Disease reservoirs can be further classified into:

1. **Primary (or Main) Reservoir**: This refers to the species that primarily harbors and transmits the pathogen, contributing significantly to its natural ecology and maintaining its transmission cycle. For example, mosquitoes are the primary reservoirs for many arboviruses like dengue, Zika, and chikungunya viruses.

2. **Amplifying Hosts**: These hosts can become infected with the pathogen and experience a high rate of replication, leading to an increased concentration of the pathogen in their bodies. This allows for efficient transmission to other susceptible hosts or vectors. For instance, birds are amplifying hosts for West Nile virus, as they can become viremic (have high levels of virus in their blood) and infect feeding mosquitoes that then transmit the virus to other animals and humans.

3. **Dead-end Hosts**: These hosts may become infected with the pathogen but do not contribute significantly to its transmission cycle, as they either do not develop sufficient quantities of the pathogen to transmit it or do not come into contact with potential vectors or susceptible hosts. For example, humans are dead-end hosts for many zoonotic diseases like rabies, as they cannot transmit the virus to other humans.

Understanding disease reservoirs is crucial in developing effective strategies for controlling and preventing infectious diseases, as it helps identify key species and environments that contribute to their persistence and transmission.

Cattle diseases are a range of health conditions that affect cattle, which include but are not limited to:

1. Bovine Respiratory Disease (BRD): Also known as "shipping fever," BRD is a common respiratory illness in feedlot cattle that can be caused by several viruses and bacteria.
2. Bovine Viral Diarrhea (BVD): A viral disease that can cause a variety of symptoms, including diarrhea, fever, and reproductive issues.
3. Johne's Disease: A chronic wasting disease caused by the bacterium Mycobacterium avium subspecies paratuberculosis. It primarily affects the intestines and can cause severe diarrhea and weight loss.
4. Digital Dermatitis: Also known as "hairy heel warts," this is a highly contagious skin disease that affects the feet of cattle, causing lameness and decreased productivity.
5. Infectious Bovine Keratoconjunctivitis (IBK): Also known as "pinkeye," IBK is a common and contagious eye infection in cattle that can cause blindness if left untreated.
6. Salmonella: A group of bacteria that can cause severe gastrointestinal illness in cattle, including diarrhea, dehydration, and septicemia.
7. Leptospirosis: A bacterial disease that can cause a wide range of symptoms in cattle, including abortion, stillbirths, and kidney damage.
8. Blackleg: A highly fatal bacterial disease that causes rapid death in young cattle. It is caused by Clostridium chauvoei and vaccination is recommended for prevention.
9. Anthrax: A serious infectious disease caused by the bacterium Bacillus anthracis. Cattle can become infected by ingesting spores found in contaminated soil, feed or water.
10. Foot-and-Mouth Disease (FMD): A highly contagious viral disease that affects cloven-hooved animals, including cattle. It is characterized by fever and blisters on the feet, mouth, and teats. FMD is not a threat to human health but can have serious economic consequences for the livestock industry.

It's important to note that many of these diseases can be prevented or controlled through good management practices, such as vaccination, biosecurity measures, and proper nutrition. Regular veterinary care and monitoring are also crucial for early detection and treatment of any potential health issues in your herd.

African Swine Fever (ASF) is a highly contagious and deadly viral disease that affects both domestic and wild pigs. It is caused by the African swine fever virus (ASFV), which belongs to the Asfarviridae family. The disease is not zoonotic, meaning it does not infect or cause disease in humans.

Clinical signs of ASF can vary depending on the strain of the virus and the age and overall health status of the infected pig. However, common symptoms include high fever, loss of appetite, weakness, skin redness or blueness, diarrhea, vomiting, coughing, difficulty breathing, and abortion in pregnant sows. In severe cases, ASF can cause sudden death within a few days after infection.

ASF is transmitted through direct contact with infected pigs or their body fluids, as well as through contaminated feed, water, and fomites (inanimate objects). The virus can also be spread by soft ticks of the genus Ornithodoros, which can transmit the virus to wild suids such as warthogs and bushpigs.

There is no effective treatment or vaccine available for ASF, and control measures rely on early detection, quarantine, and culling of infected animals. Prevention measures include strict biosecurity protocols, restriction of pig movements, and proper disposal of carcasses and waste.

ASF is endemic in many African countries and has spread to other parts of the world, including Europe, Asia, and South America. It poses a significant threat to the global pork industry due to its high mortality rate and lack of effective control measures.

"Cattle" is a term used in the agricultural and veterinary fields to refer to domesticated animals of the genus *Bos*, primarily *Bos taurus* (European cattle) and *Bos indicus* (Zebu). These animals are often raised for meat, milk, leather, and labor. They are also known as bovines or cows (for females), bulls (intact males), and steers/bullocks (castrated males). However, in a strict medical definition, "cattle" does not apply to humans or other animals.

I'm sorry for any confusion, but "Nigeria" is not a medical term. It is a country located in West Africa, and it is the most populous country in Africa. If you have any questions about medical conditions or terms, I would be happy to help clarify those for you.

I'm sorry for any confusion, but "Kenya" is not a medical term. It is the name of a country located in East Africa, known for its diverse wildlife and geography, including savannas, lakelands, the dramatic Great Rift Valley, and mountain highlands. It is also where you can find the Maasai Mara Reserve, known for its annual wildebeest migrations, and vast Nairobi National Park. The capital city of Kenya is Nairobi. If you have any questions about medical terms or concepts, I would be happy to help with those!

Preclinical drug evaluation refers to a series of laboratory tests and studies conducted to determine the safety and effectiveness of a new drug before it is tested in humans. These studies typically involve experiments on cells and animals to evaluate the pharmacological properties, toxicity, and potential interactions with other substances. The goal of preclinical evaluation is to establish a reasonable level of safety and understanding of how the drug works, which helps inform the design and conduct of subsequent clinical trials in humans. It's important to note that while preclinical studies provide valuable information, they may not always predict how a drug will behave in human subjects.

Central nervous system (CNS) diseases refer to medical conditions that primarily affect the brain and spinal cord. The CNS is responsible for controlling various functions in the body, including movement, sensation, cognition, and behavior. Therefore, diseases of the CNS can have significant impacts on a person's quality of life and overall health.

There are many different types of CNS diseases, including:

1. Infectious diseases: These are caused by viruses, bacteria, fungi, or parasites that infect the brain or spinal cord. Examples include meningitis, encephalitis, and polio.
2. Neurodegenerative diseases: These are characterized by progressive loss of nerve cells in the brain or spinal cord. Examples include Alzheimer's disease, Parkinson's disease, and Huntington's disease.
3. Structural diseases: These involve damage to the physical structure of the brain or spinal cord, such as from trauma, tumors, or stroke.
4. Functional diseases: These affect the function of the nervous system without obvious structural damage, such as multiple sclerosis and epilepsy.
5. Genetic disorders: Some CNS diseases are caused by genetic mutations, such as spinal muscular atrophy and Friedreich's ataxia.

Symptoms of CNS diseases can vary widely depending on the specific condition and the area of the brain or spinal cord that is affected. They may include muscle weakness, paralysis, seizures, loss of sensation, difficulty with coordination and balance, confusion, memory loss, changes in behavior or mood, and pain. Treatment for CNS diseases depends on the specific condition and may involve medications, surgery, rehabilitation therapy, or a combination of these approaches.

Nitroreductases are a group of enzymes that can reduce nitro groups (-NO2) to nitroso groups (-NHOH) or amino groups (-NH2) in various organic compounds. These enzymes are widely distributed in nature and found in many different types of organisms, including bacteria, fungi, plants, and animals.

In medicine, nitroreductases have been studied for their potential role in the activation of certain drugs or prodrugs. For example, some anticancer agents such as CB1954 (also known as 5-(aziridin-1-yl)-2,4-dinitrobenzamide) are relatively inert until they are reduced by nitroreductases to more reactive metabolites that can interact with DNA and other cellular components. This property has been exploited in the development of targeted cancer therapies that selectively deliver prodrugs to tumor cells, where they can be activated by endogenous nitroreductases to kill the cancer cells while minimizing toxicity to normal tissues.

Nitroreductases have also been implicated in the development of bacterial resistance to certain antibiotics, such as metronidazole and nitrofurantoin. These drugs are activated by nitroreductases in bacteria, but overexpression or mutation of the enzyme can lead to reduced drug activation and increased resistance.

Emerging communicable diseases are infections whose incidence has increased in the past two decades or threatens to increase in the near future. These diseases can be caused by new microbial agents, or by previously known agents that have newly acquired the ability to cause disease in humans. They may also result from changes in human demographics, behavior, or travel patterns, or from technological or environmental changes. Examples of emerging communicable diseases include COVID-19, Ebola virus disease, Zika virus infection, and West Nile fever.

The ribosomal spacer in DNA refers to the non-coding sequences of DNA that are located between the genes for ribosomal RNA (rRNA). These spacer regions are present in the DNA of organisms that have a nuclear genome, including humans and other animals, plants, and fungi.

In prokaryotic cells, such as bacteria, there are two ribosomal RNA genes, 16S and 23S, separated by a spacer region known as the intergenic spacer (IGS). In eukaryotic cells, there are multiple copies of ribosomal RNA genes arranged in clusters called nucleolar organizer regions (NORs), which are located on the short arms of several acrocentric chromosomes. Each cluster contains hundreds to thousands of copies of the 18S, 5.8S, and 28S rRNA genes, separated by non-transcribed spacer regions known as internal transcribed spacers (ITS) and external transcribed spacers (ETS).

The ribosomal spacer regions in DNA are often used as molecular markers for studying evolutionary relationships among organisms because they evolve more rapidly than the rRNA genes themselves. The sequences of these spacer regions can be compared among different species to infer their phylogenetic relationships and to estimate the time since they diverged from a common ancestor. Additionally, the length and composition of ribosomal spacers can vary between individuals within a species, making them useful for studying genetic diversity and population structure.

Latex fixation tests are diagnostic procedures used to detect the presence of certain antigens or antibodies in a patient's sample, such as blood or serum. These tests use latex particles that are coated with specific antigens or antibodies that can bind to complementary antigens or antibodies present in the sample. When the sample is added to the latex reagent, if the specific antigen or antibody is present, they will bind to the latex particles, forming an agglutination reaction that can be seen as a visible clumping or agglutination of the latex particles.

Latex fixation tests are commonly used in the diagnosis of infectious diseases, autoimmune disorders, and genetic disorders. For example, a latex fixation test may be used to detect the presence of Streptococcus pneumoniae antigens in a patient's sputum sample or to identify the presence of rheumatoid factor (RF) antibodies in a patient's blood sample. These tests are known for their simplicity, speed, and sensitivity, making them a valuable tool in clinical laboratories.

Antigens are substances (usually proteins) found on the surface of cells, or viruses, that can be recognized by the immune system and stimulate an immune response. In the context of protozoa, antigens refer to the specific proteins or other molecules found on the surface of these single-celled organisms that can trigger an immune response in a host organism.

Protozoa are a group of microscopic eukaryotic organisms that include a diverse range of species, some of which can cause diseases in humans and animals. When a protozoan infects a host, the host's immune system recognizes the protozoan antigens as foreign and mounts an immune response to eliminate the infection. This response involves the activation of various types of immune cells, such as T-cells and B-cells, which recognize and target the protozoan antigens.

Understanding the nature of protozoan antigens is important for developing vaccines and other immunotherapies to prevent or treat protozoan infections. For example, researchers have identified specific antigens on the surface of the malaria parasite that are recognized by the human immune system and have used this information to develop vaccine candidates. However, many protozoan infections remain difficult to prevent or treat, and further research is needed to identify new targets for vaccines and therapies.

Ulcer of human African trypanosomiasis Typical fine-spotted pink rash of acute African trypanosomiasis on the skin of the ... "East African Trypanosomiasis FAQs". Parasites - African Trypanosomiasis (also known as Sleeping Sickness). Centers for Disease ... "West African Trypanosomiasis FAQs". Parasites - African Trypanosomiasis (also known as Sleeping Sickness). Centers for Disease ... "CDC - African Trypanosomiasis - General Information - East African Trypanosomiasis FAQs". www.cdc.gov. 22 April 2019. Retrieved ...
Finelle, P. "African animal trypanosomiasis". Food and Agriculture Organization of the United Nations (FAO). Retrieved 19 April ... "Human African trypanosomiasis (sleeping sickness)". Fact sheet. World Health Organization (WHO). 10 January 2022. Courtin D, ... Uilenberg, G. (1998). "African animal trypanosomes". A field guide for the diagnosis, treatment and prevention of African ... "African Animal Trypanosomiasis" (PDF). Caragata, E.; Dong, S.; Dong, Y.; Simoes, M.; Tikhe, C.; Dimopoulos, G. (2020). " ...
In humans this includes African trypanosomiasis and Chagas disease. A number of other diseases occur in other animals. African ... Nagana, or animal African trypanosomiasis, also called 'Souma' or 'Soumaya' in Sudan. Surra Mal de cadeiras, or Quebra Bunda ( ... "Trypanosomiasis, Human African (sleeping sickness)". Fact sheet N°259. World Health Organization. Retrieved 25 February 2014. ... The main approaches to controlling African trypanosomiasis are to reduce the reservoirs of infection and the presence of the ...
Eradication of infectious diseases § African trypanosomiasis Trypanocidal agent "US Fraunhofer Center receives Grant from the ... A Trypanosomiasis vaccine is a vaccine against trypanosomiasis. No effective vaccine currently exists, but development of a ... Radwanska M, Guirnalda P, De Trez C, Ryffel B, Black S, Magez S (May 2008). Riley EM (ed.). "Trypanosomiasis-Induced B Cell ... "Trypanosomiasis". Retrieved 2009-01-15. Lalmanach G, Boulangé A, Serveau C, et al. (May 2002). "Congopain from Trypanosoma ...
"African trypanosomiasis". World Health Organization. August 2006. Archived from the original on 2016-12-04. Retrieved 2020-10- ... The three major human diseases caused by trypanosomatids are; African trypanosomiasis (sleeping sickness, caused by Trypanosoma ... July 2002). "Treatment of human African trypanosomiasis-present situation and needs for research and development". Lancet ... PMID 16504583.{{cite journal}}: CS1 maint: multiple names: authors list (link) "Trypanosomiasis, human African (sleeping ...
The Pan African Tsetse and Trypanosomiasis Eradication Campaign (PATTEC) works to eradicate the tsetse fly vector population ... "Trypanosomiasis, human African (Sleeping sickness)". "WHO; World Health Organization". apps.who.int. Mehlitz, D.; Molyneux, D.H ... Brun R, Blum J, Chappuis F, Burri C (January 2010). "Human African trypanosomiasis". Lancet. 375 (9709): 148-59. doi:10.1016/ ... Schofield CJ, Kabayo JP (August 2008). "Trypanosomiasis vector control in Africa and Latin America". Parasites & Vectors. 1 (1 ...
"Human African trypanosomiasis". Lancet. 390 (10110): 2397-2409. doi:10.1016/S0140-6736(17)31510-6. PMID 28673422. S2CID 4853616 ... However, arsenicals such as melarsoprol are still used for the treatment of trypanosomiasis, since although these drugs have ...
... as well as in the treatment of African trypanosomiasis (sleeping sickness), especially the West African form (Trypanosoma ... However, since African trypanosomiasis has a high mortality rate if left untreated, treatment with eflornithine may justify any ... Because treatment for African trypanosomiasis is short-term, patients are unlikely to experience hearing loss. No interaction ... "CDC - African Trypanosomiasis - Resources for Health Professionals". www.cdc.gov. 10 August 2016. Archived from the original on ...
"Trypanosomiasis, human African (sleeping sickness)". World Health Organization. February 2016. Archived from the original on 4 ... Melarsoprol was used to treat a patient with second-stage African trypanosomiasis on season 1 episode 7 "Fidelity" of the ... Melarsoprol is an arsenic-containing medication used for the treatment of sleeping sickness (African trypanosomiasis). It is ... CDC (2013). "Disease Control and Prevention: Parasites - African Trypanosomiasis". Archived from the original on 2017-06-19. {{ ...
"CDC - African Trypanosomiasis - Biology". www.cdc.gov. 2019-06-12. Retrieved 2020-04-22. Funk, Sebastian; Nishiura, Hiroshi; ... Elephants: A necroscopy of a free-ranging African elephant (Loxodonta africana) in Kruger National Park in South Africa found ... is a species of African trypanosomes which are protozoan hemoflagellates responsible for trypanosomiasis (more commonly known ... The Role of Animal Reservoirs in Maintaining Gambiense Human African Trypanosomiasis". PLOS Computational Biology. 9 (1): ...
In African trypanosomiasis it is used for early disease before central nervous system involvement, as a second line option to ... "Trypanosomiasis, human African (sleeping sickness)". World Health Organization. February 2016. Archived from the original on 4 ... Pentamidine was first used to treat African trypanosomiasis in 1937 and leishmaniasis in 1940 before it was registered as ... Pentamidine is an antimicrobial medication used to treat African trypanosomiasis, leishmaniasis, Balamuthia infections, ...
... called African trypanosomiasis, human African trypanosomiasis (HAT) or sleeping sickness. An estimated 60-70 million people in ... Economics of African trypanosomiasis. In The Trypanosomiases (eds. I. Maudlin, P.H. Holmes & M.A. Miles) CABI Publishing, 2004 ... implementation of tsetse control operations Programme Against African Trypanosomiasis PAN AFRICAN TSETSE AND TRYPANOSOMIASIS ... Trypanosomiasis, tsetse and Africa. The year 2001 report. Aylesford, UK, Department for International Development. Simarro, P. ...
Mulligan, H. W. (Hugh Waddell) (1970). The African trypanosomiases. Potts, W. H. (William Herbert). London: Allen and Unwin. ... Typically found in sub-Saharan Africa but with a small Arabian range, G. fuscipes is a regional vector of African ... Programme Against African (2003). Economic Guidelines for Strategic Planning of Tsetse and Trypanosomiasis Control in West ... "Prospects for control of African trypanosomiasis by tsetse vector manipulation". Trends in Parasitology. 17 (1): 29-35. doi: ...
Lumsden, W. H. (1974). "Some episodes in the history of African trypanosomiasis". Proceedings of the Royal Society of Medicine ... Steverding, Dietmar (2008). "The history of African trypanosomiasis". Parasites & Vectors. 1 (1): 3. doi:10.1186/1756-3305-1-3 ... When Bruce was transferred to South Africa, he was sent to Zululand to investigate the outbreak of animal disease which the ... Bruce on the porch of his hut in Ubombo, Zululand (now South Africa), where he discovered Trypanosoma brucei. Bruce with wife ...
Trypanosomes are parasitic protozoa that cause African trypanosomiasis and Chagas disease (American trypanosomiasis). There are ... Franco JR, Simarro PP, Diarra A, Jannin JG (2014). "Epidemiology of human African trypanosomiasis". Clinical Epidemiology. 6: ... In some countries such as Brazil, Russia, India, China, and South Africa it is predicted that a 99% increase will occur. ... The protozoan parasites that cause the diseases malaria, trypanosomiasis, toxoplasmosis, cryptosporidiosis and leishmaniasis ...
American Trypanosomiasis), caused by Trypanosoma cruzi. Nifurtimox has also been used to treat African trypanosomiasis ( ... "Trypanosomiasis, human African (sleeping sickness)". World Health Organization. February 2016. Archived from the original on 4 ... It has been recommended as first-line treatment for second-stage African trypanosomiasis. Use of nifurtimox should be avoided ... July 2009). "Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis ...
Lumsden, W. H. (1974). "Some episodes in the history of African trypanosomiasis". Proceedings of the Royal Society of Medicine ... Steverding, Dietmar (2008). "The history of African trypanosomiasis". Parasites & Vectors. 1 (1): 3. doi:10.1186/1756-3305-1-3 ...
"Trypanosomiasis, human African (sleeping sickness)". World Health Organization. February 2016. Archived from the original on 4 ... Specifically, it is used for treatment of first-stage African trypanosomiasis caused by Trypanosoma brucei rhodesiense and ... Suramin is a medication used to treat African sleeping sickness and river blindness. It is the treatment of choice for sleeping ... Trypanosomiasis, Leishmaniasis, and Other Protozoal Infections". In Brunton LL, Chabner BA, Knollmann BC (eds.). Goodman and ...
"Trypanosomiasis, human African (sleeping sickness)". www.who.int. Retrieved 2023-06-16. La Greca, F.; Magez, S. (2011). " ... "Vaccination against trypanosomiasis: Can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist ... https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis). {{cite web}}: Missing or empty , ...
Steverding, D. (2008). "The History of African Trypanosomiasis". Parasites & Vectors. 1 (1): 3. doi:10.1186/1756-3305-1-3. ISSN ... Historical Dictionaries of Africa No. 109. Lanham: Scarecrow Press. p. 65. ISBN 9780810862609 Robert Michael Forde England and ... Dutton died in the Congo in 1905 from tick fever that he contracted while researching trypanosomiasis. Forde died at the ... had discovered trypanosomes in the blood of a cow in South Africa in 1894 and these were named Trypanosoma brucei in 1899. In ...
... by the British Royal Society to investigate the outbreak of African sleeping sickness or African trypanosomiasis in Africa at ... Lumsden, W. H. (1974). "Some episodes in the history of African trypanosomiasis". Proceedings of the Royal Society of Medicine ... Cox, Francis E. G. (2004). "History of sleeping sickness (African trypanosomiasis)". Infectious Disease Clinics. 18 (2): 231- ... Durban (South Africa): Bennett & Davis. p. 1. Donelson, Linda G.; Donelson, John E. (2008-02-01). "The fatal sleep: Africa's ...
Steverding, Dietmar (2008). "The history of African trypanosomiasis". Parasites & Vectors. 1 (1): 3. doi:10.1186/1756-3305-1-3 ...
Reader's Digest Association, Cape Town Steverding, Dietmar (2008). "The history of African trypanosomiasis". Parasites & ... Plains of Africa, South African English, Grasslands, Grasslands of Africa, Grasslands of South Africa, Karoo, Afrikaans words ... Atlas of Southern Africa. (1984). pp. 13, 192, 195. Reader's Digest Association, Cape Town Atlas of Southern Africa. (1984). pp ... McCarthy, T.S. (2013) The Okavango delta and its place in the geomorphological evolution of southern Africa. South African ...
Sleeping sickness, or African trypanosomiasis, is a disease that usually affects animals, but has been known to be fatal to ... Africa portal List of national parks in Africa Outline of Africa#Geography of Africa The Horn of Africa One or more of the ... Wikimedia Atlas of Africa Media related to Geography of Africa at Wikimedia Commons "Africa". Norman B. Leventhal Map Center at ... "high Africa" extending from Ethiopia down south to South Africa and the Cape of Good Hope while "low Africa" representing the ...
ISBN 978-969-494-920-8.[page needed] "CDC - African Trypanosomiasis - Disease". www.cdc.gov. 28 April 2020. Retrieved 18 July ... or African trypanosomiasis. Remittent fever, where the temperature remains above normal throughout the day and fluctuates more ...
Cox, Francis E.G (2004). "History of sleeping sickness (African trypanosomiasis)". Infectious Disease Clinics of North America ...
and this chapter... • Murray, Max; Morrison, W.; Whitelaw, D. (1982). Host Susceptibility to African Trypanosomiasis: ... N'Dama cattle West African Dwarf goats: 106 West African Dwarf sheep (Djallonké) Cameroon sheep Certain domestic ruminant ... breeds in sub-saharan Africa show remarkable resistance to the effects of African trypanosomiasis: they can tolerate the ... "Trypanotolerance in West African cattle". CIRAD (Centre de coopération internationale en recherche agronomique pour le ...
Other insects, notably the Tabanidae, cause trypanosomiasis. Attempts to immunize West African horses and donkeys were made ... The horse in West African History. The rôle of the horse in the societies of pre-colonial West Africa". Outre-Mers. Revue ... Type 9 African horse sickness has also been observed, mainly in the Savanna and Kara regions, making Togo a team focus. However ... The incidence of trypanosomiasis is decreasing due to the eradication programs of the insect vectors, which also infect cattle ...
African trypanosomiasis (sleeping sickness); respiratory disease: meningococcal meningitis, and schistosomiasis, a water ... Portuguese is the official language of Angola, but Bantu and other African languages are also widely spoken. In fact, Kikongo, ... Roughly 37% of Angolans are Ovimbundu, 25% are Ambundu, 13% are Bakongo, 2% are mestiço, 1-2% are white Africans, and people ... In addition, mixed race (European and African) people amount to about 30%, with (15%) population of whites, mainly ethnically ...
... associated with the early phase of African trypanosomiasis (African sleeping sickness), a disease caused by the parasites ... Cox F. History of sleeping sickness (African trypanosomiasis). Infectious Disease Clinics of North America - Volume 18, Issue 2 ... June 2004) CDC website on trypanosomiasis (Articles with short description, Short description is different from Wikidata, All ...
... gambiense causes a slowly progressing African trypanosomiasis in western and central Africa and T. b. rhodesiense causes a more ... African Trypanosomiasis, also known as "sleeping sickness", is caused by microscopic parasites of the species Trypanosoma ... acute African trypanosomiasis in eastern and southern Africa. Control efforts have reduced the number of annual cases and for ... www.who.int/data/gho/data/themes/topics/human-african-trypanosomiasis). Sleeping sickness is curable with medication but is ...
Ulcer of human African trypanosomiasis Typical fine-spotted pink rash of acute African trypanosomiasis on the skin of the ... "East African Trypanosomiasis FAQs". Parasites - African Trypanosomiasis (also known as Sleeping Sickness). Centers for Disease ... "West African Trypanosomiasis FAQs". Parasites - African Trypanosomiasis (also known as Sleeping Sickness). Centers for Disease ... "CDC - African Trypanosomiasis - General Information - East African Trypanosomiasis FAQs". www.cdc.gov. 22 April 2019. Retrieved ...
There is no test of cure for African trypanosomiasis. After treatment, patients should be closely followed for 24 months and ... Antitrypanosomal treatment is indicated for all persons diagnosed with African trypanosomiasis. Choice of therapy depends on ... Eflornithine is not effective against T. b. rhodesiense and it is not recommended for treating the East African form of the ... The card agglutination test for trypanosomiasis/T. b. gambiense (CATT) is a serologic screening test used for population ...
African trypanosomiasis is endemic to rural sub-Saharan Africa. T. brucei rhodesiense is reported from eastern and southeastern ... Trypanosomiasis, African. CDC Yellow Book 2024. Travel-Associated Infections & Diseases Author(s): Sharon Roy, Rebecca Chancey ... CDC website: African trypanosomiasis. The following authors contributed to the previous version of this chapter: Sharon L. Roy ... Epidemiology of human African trypanosomiasis. Clin Epidemiol. 2014;6:257-75.. Kennedy PGE. Clinical features, diagnosis, and ...
East African or Rhodesian African trypanosomiasis) T brucei gambiense (West Afric... ... is an illness endemic to sub-Saharan Africa. It is caused by the flagellate protozoan Trypanosoma brucei, which exists in the ... African trypanosomiasis, also referred to as sleeping sickness, ... African trypanosomiasis is confined to tropical Africa between ... encoded search term (African Trypanosomiasis (Sleeping Sickness)) and African Trypanosomiasis (Sleeping Sickness) What to Read ...
Human African trypanosomiasis in travellers to Kenya, Page 1 of 1 , Previous page , Next page , /docserver/preview/fulltext/ ... Human African trypanosomiasis in travellers to Kenya. Euro Surveill. 2012;17(10):pii=20109. https://doi.org/10.2807/ese.17.10. ...
Human African Trypanosomiasis. In this section:. *Number of new reported cases (T.b. gambiense) ...
Human African trypanosomiasis, also known as sleeping sickness, is only endemic in South Sudan within the WHO Eastern ... Large epidemics of human African trypanosomiasis have periodically occurred in South Sudan since the early 20th century. When ... The number of people at risk of human African trypanosomiasis is estimated at 1.8 million. ... Foci of T.b. gambiense occur in the Equatoria region, a belt bordering the Central African Republic, Democratic Republic of ...
Ibang tawag: African lethargy, sleeping sickness, Congo trypanosomiasis *↑ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 ... Ang African trypanosomiasis[1][2] ay isang karamdamang endemiko sa Aprika[3] na dulot ng parasito sa tao at ibang hayop. Ito ay ... Kennedy, PG (Pebrero 2013). "Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness ... 1939). "African lethargy". The Modern Home Physician, A New Encyclopedia of Medical Knowledge. WM. H. Wise & Company (New York ...
A spectrum of disease in human African trypanosomiasis: the host and parasite genetics of virulence. Download Prime PubMed App ... Human African trypanosomiasis: connecting parasite and host genetics.. *Human African trypanosomiasis: clinical presentation ... Treatment of human African trypanosomiasis with natural products (Review).. *[Distribution and spread of human African ... A spectrum of disease in human African trypanosomiasis: the host and parasite genetics of virulence.. Parasitology. 2010 Dec; ...
Summary: Few therapeutic options are available to treat the late-stage of human African trypanosomiasis, a neglected tropical ... Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: A pivotal multicentre, randomized, non- ... Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with ...
African Trypanosomiasis - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - Medical ... African Trypanosomiasis (African Sleeping Sickness; Human African Trypanosomiasis; HAT). By Chelsea Marie , PhD, University of ... Treatment of African Trypanosomiasis Treatment of African trypanosomiasis is guided by species and stage of disease. ... Prevention of African Trypanosomiasis Prevention of African trypanosomiasis includes avoiding endemic areas and protecting ...
This paper proposes an exploratory spatial analysis using geo-referenced human African trypanosomiasis (HAT) cases and matched ... Human African trypanosomiasis data. A matched case-control study design was used; passively detected Rhodesian HAT case records ... Simarro PP, Cecchi G, Paone M, Franco JR, Diarra A, Ruiz JA, et al: The Atlas of human African trypanosomiasis: a contribution ... Laveissière C, Sane B, Meda HA: Measurement of risk in endemic areas of human African trypanosomiasis in Cote-Divoire. Trans R ...
Author(s): Aksoy, Serap; Attardo, Geoffrey; Berriman, Matt; Christoffels, Alan; Lehane, Mike; Masiga, Dan; Toure, Yeya
African Trypanosomiasis Pipeline Insight Report: The report covers the dormant and discontinued pipeline projects related to ... and molecule type for African Trypanosomiasis. Price : Single User $1250, Industry Forecast: 2019, Region: Global ... the African Trypanosomiasis. It Provides pipeline assessment by monotherapy and combination therapy products, stage of ... 2. African Trypanosomiasis Overview. 3. Pipeline Therapeutics. • An Overview of Pipeline Products for African Trypanosomiasis. ...
Surgical intervention is not recommended for the management of African trypanosomiasis. Surgery. Surgical intervention is not ... Retrieved from "https://www.wikidoc.org/index.php?title=African_trypanosomiasis_surgery&oldid=1634469" ...
Lejon, V. / Neuro-inflammation in human West-African trypanosomiasis: a basis for improved stage determination. Antwerpen : ... Lejon V. Neuro-inflammation in human West-African trypanosomiasis: a basis for improved stage determination. Antwerpen: ... Lejon, V. (2002). Neuro-inflammation in human West-African trypanosomiasis: a basis for improved stage determination. ... Lejon, V 2002, Neuro-inflammation in human West-African trypanosomiasis: a basis for improved stage determination, Antwerpen. ...
Animal African Trypanosomiasis. Glasgow is collaborating with other universities to tackle this devastating parasitic disease. ...
Human African trypanosomiasis Nigerian Institution for Trypanosomiasis and Onchocerciasis. Selected secondary schools in rural ... Human African trypanosomiasis Global Shapers Harare Hub. With over 60% of Zimbabweans affected by NTDs , we plan on hosting a ... Human African trypanosomiasis Swiss Tropical and Public Health Institute. Swiss TPH will be present at the National Day of ... In honor of the DRCs Third Annual National Human African Trypanosomiasis (HAT) Day and First Annual World NTD Day on January ...
HAT is found only in sub-Saharan Africa. Two subspecies of Trypanosoma brucei cause disease: T. b. gambiense in West and ... Central Africa, and T. b. rhodesiense in East Africa. This life-threatening disease mostly affects poor rural populations, ... Human African trypanosomiasis (HAT), or sleeping sickness, is caused by trypanosome parasites that are transmitted by tsetse ... Trypanosomiasis, human African (sleeping sickness). Human African trypanosomiasis (HAT), or sleeping sickness, is caused by ...
Chemotherapy for second-stage Human African trypanosomiasis. Chemotherapy for second-stage Human African trypanosomiasis. * ... Human African trypanosomiasis, or sleeping sickness, is a painful and protracted disease affecting people in the poorest parts ... To evaluate the effectiveness and safety of drugs for treating second-stage human African trypanosomiasis. ... of Africa and is fatal without treatment. Few drugs are currently available for second-stage sleeping sickness, with ...
Bovine trypanosomiasis susceptibility of East African cattle to African trypanosomiasis / by Monirei, Joseph Meeli. by Monirei ... Results of search for su:{Trypanosomiasis, African} Refine your search. *. Availability. * Limit to currently available items ... The African trypanosomiases / edited by H. W. Mulligan, with the help, for part II, of W. H. Potts. by Mulligan, Hugh Waddell. ... by Joint FAO/WHO Expert Committee on African Trypanosomiasis , World Health Organization , Food and Agriculture Organization of ...
Molecular basis for Control of African Trypanosomiasis and Equine Laminitis. Molecular Basis of Immunity against African ... 2001). Innate and acquired resistance to African trypanosomiasis. The Journal of parasitology, 87(1), 1-9. presented at the ... These trypanosomiasis-resistant bovids co-evolved with African trypanosomes and efficiently suppress trypanosome parasitemia to ... Trypanosomiasis precludes cattle-based agriculture from much of this area and threatens up to 60 million people, of whom about ...
Geospatial datasets and analyses for an environmental approach to African trypanosomiasis. Geospatial datasets and analyses for ... This review is followed by three case studies from two countries affected by trypanosomiasis (Burkina Faso and Botswana). The ... management and analysis in the context of area-wide integrated management of tsetse and trypanosomiasis. ... a cross-section of actual and potential applications of GIS in the context of interventions against tsetse and trypanosomiasis ...
Also, the Atlas will help streamline future field data collection in those parts of Africa that still require it. ... Data from Cameroon, Central African Republic, Chad, Congo, Equatorial Guinea and Gabon from the year 2000 onwards were fully ... within a defined geographical entity were chosen as the key variables to map disease distribution in sub-Saharan Africa. At the ... accurate and comprehensive information on the distribution of human African trypanosomiasis (HAT), also known as sleeping ...
The project, "Diagnostic tools for human African trypanosomiasis elimination and clinical trials" abbreviated as DiTECT-HAT ... is a recent project that we are collaboratively working on in West Africa. The project is funded by the Horizon 2020-The EU ...
Human African trypanosomiasis (HAT). Human African Trypanosomiasis, also called sleeping sickness, is a fatal disease if left ... Arfican trypanosomesDisease vectorsentomologyHuman African Trypanosomiasissleeping sicknesstiny targetsTrypanosomiasistseste ... What influences the cost of vector control in Human African Trypanosomiasis (HAT) elimination?. In a recent study, researchers ... in west and central Africa and the Rhodesiense form (rHAT) in eastern and southern Africa. ...
Camel trypanosomiasis or surra is of great concern in Somalia, since the country possesses the largest one-humped camel ( ... Animal and Human African trypanosomiasis (AAT and HAT, respectively) remain significant health and economic concern in Africa. ... African animal trypanosomiasis (AAT) is one of the major constraints of the livestock industry in developing countries of ... African animal trypanosomiasis (AAT) affects the livestock of 12.3 million Somalis and constrains their development and ...
Only two trypanosome subspecies are able to cause human African trypanosomiasis. To establish an infection in human blood, they ... The structure of serum resistance-associated protein and its implications for human African trypanosomiasis. ... Only two trypanosome subspecies are able to cause human African trypanosomiasis. To establish an infection in human blood, they ... The structure of serum resistance-associated protein and its implications for human African trypanosomiasis. ...
  • All six patients have shared several characteristics: exposure to infected tsetse flies while visiting game parks in eastern or southern Africa, development of acute, febrile illness consistent with Trypanosoma brucei rhodesiense infection 1-21 days after visiting Editorial Note: This is the sixth published report since 1967 of imported African trypanosomiasis (African sleeping sickness) in Americans (1). (cdc.gov)
  • All six patients have shared several characteristics: exposure to infected tsetse flies while visiting game parks in eastern or southern Africa, development of acute, febrile illness consistent with Trypanosoma brucei rhodesiense infection 1-21 days after visiting the game parks, detectable typanosomes on peripheral blood smears, and recovery after appropriate therapy. (cdc.gov)
  • Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial. (medscape.com)
  • Trypanosomiasis is caused by 2 subspecies of the protozoan parasite Trypanosoma brucei ( T. brucei rhodesiense and T. brucei gambiense ). (cdc.gov)
  • Human African trypanosomiasis (HAT), or sleeping sickness, caused by Trypanosoma brucei gambiense , is associated with diverse clinical outcomes. (scirp.org)
  • Human African trypanosomiasis (HAT), or sleeping sickness, caused by Trypanosoma brucei gambiense (T. b. gambiense) is classically described as a chronic infection characterized by an early hemolymphatic stage (stage 1) associated with nonspecific symptoms such as intermittent fevers and headaches, followed by a meningoencephalitic stage (stage 2) in which the parasite invades the central nervous system and causes neurological disorders and death if left untreated. (scirp.org)
  • Trypanosoma brucei rhodesiense (East African or Rhodesian African trypanosomiasis) transmitted by infected tsetse flies ( Glossina morsitans ). (medscape.com)
  • Trypanosoma brucei gambiense (West African or Gambian African trypanosomiasis) transmitted by infected tsetse flies ( Glossina palpalis ). (medscape.com)
  • Human African trypanosomiasis is infection with protozoa of the species Trypanosoma brucei , transmitted by the bite of a tsetse fly. (msdmanuals.com)
  • Human African trypanosomiasis (HAT) is a neglected tropical disease caused by Trypanosoma brucei gambiense transmitted by tsetse flies in sub-Saharan West Africa. (pubfacts.com)
  • African trypanosomiasis is caused by parasites of the genus Trypanosoma and transmitted by infected tsetse flies and is endemic in 36 sub-Saharan African countries where there are tsetse flies that transmit the disease. (apnaupchar.com)
  • Human African trypanosomiasis takes 2 forms, depending on the subspecies of the parasite involved: Trypanosoma brucei gambiense accounts for more than 95% of reported cases. (apnaupchar.com)
  • African Trypanosomiasis, otherwise called "dozing ailment", is brought about by infinitesimal parasites of the species Trypanosoma brucei. (apnaupchar.com)
  • African trypanosomiasis caused by Trypanosoma brucei gambiense has not been reported in Italy. (cdc.gov)
  • Two subspecies of Trypanosoma brucei cause disease: T. b. gambiense in West and Central Africa, and T. b. rhodesiense in East Africa. (who.int)
  • Fexinidazole Tablets is a nitroimidazole antimicrobial, indicated for the treatment of both first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in patients 6 years of age and older and weighing at least 20 kg. (nih.gov)
  • Human African trypanosomiasis, caused by the eukaryotic parasite Trypanosoma brucei, is a serious health problem in much of central Africa. (nih.gov)
  • Infection with the parasite Trypanosoma brucei gambiense ( T.b. gambiense ) causes the chronic form of human African trypanosomiasis (HAT), also called sleeping sickness. (biomedcentral.com)
  • Human African trypanosomosis (HAT) is caused by Trypanosoma brucei rhodesiense and other species and transmitted by tsetse flies, which are equally spreading to other part of Africa (.Doua and Yapo 2001). (ispub.com)
  • The African trypanosome Trypanosoma brucei gambiense is a parasite responsible for chronic Human African Trypanosomiasis, more commonly known as sleeping. (pasteur.fr)
  • The only validated molecular target for treatment of human African trypanosomiasis is ornithine decarboxylase (ODC), which catalyzes the first step in polyamine metabolism. (nih.gov)
  • Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo. (medscape.com)
  • Foci of T.b. gambiense occur in the Equatoria region, a belt bordering the Central African Republic, Democratic Republic of Congo and Uganda. (who.int)
  • In residents of endemic areas, the clinical course of disease caused by T. brucei gambiense generally progresses more slowly (estimated average total duration of 3 years) than that caused by T. brucei rhodesiense , but if not treated, both forms of African trypanosomiasis typically are fatal. (cdc.gov)
  • In 2021, approximately 800 combined cases were reported to the WHO, with over 90% caused by T. b. gambiense (see WHO: Human African trypanosomiasis ). (msdmanuals.com)
  • Two morphologically vague subspecies of the parasite cause particular sickness designs in people: T. b. gambiense causes a gradually advancing African trypanosomiasis in western and focal Africa and T. b. rhodesiense causes more intense African trypanosomiasis in eastern and southern Africa. (apnaupchar.com)
  • T. b. gambiense , which is found in western and central Africa, causes chronic disease, while T. b. rhodesiense , which is found in eastern and southern Africa, causes acute severe disease. (cdc.gov)
  • We report 2 cases of imported trypanosomiasis gambiense in Italy during the summer of 2004. (cdc.gov)
  • Editorial Note: This is the sixth published report since 1967 of imported African trypanosomiasis (African sleeping sickness) in Americans (1). (cdc.gov)
  • African trypanosomiasis, also known as African sleeping sickness or simply sleeping sickness, is an insect-borne parasitic infection of humans and other animals. (wikipedia.org)
  • In stage 1 (early or hemolymphatic stage) African trypanosomiasis (sleeping sickness), differential diagnoses of recurrent fever include malaria, HIV infection, borreliosis, brucellosis, typhoid fever, and other enteric fevers. (medscape.com)
  • Parasites - African Trypanosomiasis (also known as Sleeping Sickness). (medscape.com)
  • Human African trypanosomiasis, or sleeping sickness, is a widespread tropical disease that can be fatal if not treated. (who.int)
  • Sleeping sickness occurs in 36 sub-Saharan Africa countries where there are tsetse flies that transmit the disease. (who.int)
  • Human African trypanosomiasis, also known as sleeping sickness, is a vector-borne parasitic disease. (who.int)
  • Human African trypanosomiasis, also known as sleeping sickness, is only endemic in South Sudan within the WHO Eastern Mediterranean Region. (who.int)
  • African trypanosomiasis (sleeping sickness) is an illness endemic to sub-Saharan Africa. (medscape.com)
  • When I volunteered several years ago as a physician in a small hospital in West Africa, one of the most frustrating and frightening diseases I saw was sleeping sickness. (nih.gov)
  • The next year, while studying abroad in England, Mugnier met a researcher who had studied one of the most devious of parasites-a protozoan, spread by blood-sucking tsetse flies, that causes sleeping sickness in humans and livestock across sub-Saharan Africa. (nih.gov)
  • Involvement of the central nervous system produces "African sleeping sickness. (sdsu.edu)
  • Human African trypanosomiasis (HAT), also known as sleeping sickness, is caused by a flagellated trypanosome protozoan and transmitted by Glossina (tsetse) flies. (cdc.gov)
  • Human African trypanosomiasis (HAT), or sleeping sickness, is caused by trypanosome parasites that are transmitted by tsetse flies. (who.int)
  • Agents of African trypanosomiasis (sleeping sickness). (medlineplus.gov)
  • BACKGROUND: Human African trypanosomiasis, or sleeping sickness, is a painful and protracted disease affecting people in the poorest parts of Africa and is fatal without treatment. (unl.pt)
  • Diagnosis of sleeping sickness, a neglected tropical disease caused by African trypanosomes, relies on the detection of parasites in blood. (pasteur.fr)
  • African Sleeping Sickness affects 30,000 people every year. (kenyon.edu)
  • African Trypanosomiasis, or better known as African Sleeping Sickness, is a parasite driven infection of the human nervous system. (kenyon.edu)
  • The tsetse fly is a pan-African insect that bites an infective forest animal and ingests blood filled with invisible parasites, which it carries and transmits into cattle and people as it bites them, leading to n'gana (animal trypanosomiasis) and sleeping sickness. (mit.edu)
  • Trypanosomiasis is transmitted by the bite of an infected tsetse fly ( Glossina spp. (cdc.gov)
  • Genomic evidence of sex chromosome aneuploidy and infection-associated genotypes in the tsetse fly Glossina fuscipes, the major vector of African trypanosomiasis in Uganda. (pubfacts.com)
  • The primary vector of the trypanosome parasite causing human and animal African trypanosomiasis in Uganda is the riverine tsetse fly Glossina fuscipes fuscipes (Gff). (pubfacts.com)
  • It is sent by the tsetse fly (Glossina species), which is tracked down just in sub-Saharan Africa. (apnaupchar.com)
  • Focuses on the impact of African trypanosomiasis, carried by the tsetse fly, on people, livestock, water supplies, and overall well-being in equatorial Africa. (nih.gov)
  • Unsurprisingly, across the 36 African countries that it is found in, the tsetse fly is known to carry a variety of trypanosomiasis infections. (kenyon.edu)
  • How the presence of the tsetse fly turned the African forest into an open laboratory where African knowledge formed the basis of colonial tsetse control policies. (mit.edu)
  • In The Mobile Workshop , Clapperton Chakanetsa Mavhunga examines how the presence of the tsetse fly turned the forests of Zimbabwe and southern Africa into an open laboratory where African knowledge formed the basis of colonial tsetse control policies. (mit.edu)
  • Mavhunga's account restores the central role not just of African labor but of African intellect in the production of knowledge about the tsetse fly. (mit.edu)
  • A bold intellectual contribution to the history of science and technology that gives readers not only an African history of mhesvi , the tsetse fly, and its management but also an argument for why we must go beyond colonial, postcolonial, and decolonial frames when studying knowledge production in places such as Africa. (mit.edu)
  • Trypanosomiasis rhodesiense is a zoonosis, and humans visiting affected areas (usually for hunting or tourism) are accidental hosts. (cdc.gov)
  • African trypanosomiasis is endemic to rural sub-Saharan Africa. (cdc.gov)
  • Human African trypanosomiasis (HAT) can affect travelers to sub-Saharan Africa, as well as migrants from disease endemic countries (DECs), posing diagnosis challenges to travel health services in non-disease endemic countries (non-DECs). (nih.gov)
  • A disease endemic among people and animals in Central Africa. (sdsu.edu)
  • Theses cases suggest an increased risk for expatriates working in trypanosomiasis-endemic countries. (cdc.gov)
  • Dracunculiasis is now only endemic in 5 countries in Africa, transmission having been eliminated from Asia. (biomedcentral.com)
  • Passive diagnosis of human African trypanosomiasis (HAT) at the health facility level is a major component of HAT control in Guinea. (biomedcentral.com)
  • Suramin is recommended for treating the hemolymphatic stage of African trypanosomiasis, but because it does not cross the blood-brain barrier, it is ineffective against trypanosomes in the CNS. (cdc.gov)
  • African trypanosomiasis symptoms occur in two stages: the hemolymphatic stage and the neurological stage (the latter being characterised by parasitic invasion of the central nervous system). (wikipedia.org)
  • Encouraging examples of successful control and elimination of parasites and their vectors are now being reported in other settings and at a larger scale, including filariasis in China, Sri Lanka and the Republic of Korea and onchocerciasis in the Americas and in some settings in West Africa. (biomedcentral.com)
  • Caused by a parasite transmitted from tsetse flies, human African trypanosomiasis can lead to headaches, fever, weakness, and stiffness. (nih.gov)
  • See World Health Organization (WHO) maps and tables of African trypanosomiasis cases, by country . (cdc.gov)
  • As many as 70,000 people are infected in Central and East Africa. (genome.gov)
  • If you have traveled or lived in West or Central Africa, you may be infected with certain parasites (such as Loa loa, African trypanosomiasis) that could cause problems with ivermectin treatment. (webmd.com)
  • Although general laboratory studies may be helpful, a definitive diagnosis of African trypanosomiasis requires actual detection of trypanosomes. (medscape.com)
  • Late in the course of African trypanosomiasis, trypanosomes appear in the interstitial fluid of many organs, including the myocardium and eventually the central nervous system. (msdmanuals.com)
  • Epidemiology of human African trypanosomiasis. (medscape.com)
  • In this study an attempt has been made to investigate the epidemiology of animal trypanosomiasis in Zambia and to evaluate the efficiency of the currently used drug regime for the control of the disease. (gla.ac.uk)
  • In Africa in general, and in Angola in particular, the epidemiology and public health impact of DENV is far from clear. (unl.pt)
  • Paris, France, 20th May, 2023: On May 21st, 2023, the inauguration of the PanAfrican Secretariat for Peste des Petits Ruminants (PPR) Eradication in Africa is scheduled to occur in Paris, France. (au-ibar.org)
  • People most likely to be exposed to African trypanosomiasis infection are hunters and villagers with infected cattle herds. (cdc.gov)
  • Two returning safari tourists with African trypanosomiasis were admitted to the Hospital for Tropical Diseases, London, in a 3-day period, compared with six cases in the previous 14 years. (medscape.com)
  • Courtesy of the CDC Division of Parasitic Diseases and Malaria (DPDx at https://www.cdc.gov/dpdx/trypanosomiasisafrican/index.html). (medscape.com)
  • The diseases are most heavily concentrated in low-income nations in Africa and Latin America. (genome.gov)
  • Tsetse flies are cyclical vectors of African trypanosomiasis (AT). (pubfacts.com)
  • Truc P, Lando A, Penchenier L, Vatunga G, Josenando T. Human African trypanosomiasis in Angola: clinical observations, treatment, and use of PCR for stage determination of early stage of the disease. (medscape.com)
  • Risk for human african trypanosomiasis, central Africa, 2000-2009. (medscape.com)
  • Bonnet J, Boudot C, Courtioux B. Overview of the Diagnostic Methods Used in the Field for Human African Trypanosomiasis: What Could Change in the Next Years? (medscape.com)
  • Development of multiplex serological assay for the detection of human African trypanosomiasis. (medscape.com)
  • The number of people at risk of human African trypanosomiasis is estimated at 1.8 million. (who.int)
  • Large epidemics of human African trypanosomiasis have periodically occurred in South Sudan since the early 20th century. (who.int)
  • Despite improvements in treatments for human African trypanosomiasis (HAT), there is a risk of relapse. (dndi.org)
  • This finding has relevance to trypanosomiasis of domestic animals in which Berenil is a commonly used drug and also to human trypanosomiasis which, in the late stages of the disease, affects the central nervous system. (gla.ac.uk)
  • Human African Trypanosomiasis in the Democratic Republic of the Congo: A Looming Emergency? (msfaccess.org)
  • the major vector of human African trypanosomiasis. (pubfacts.com)
  • In southern Chad the most active and persistent focus is the Mandoul focus, with 98% of the reported human cases, and where African animal trypanosomosis (AAT) is also present. (pubfacts.com)
  • The establishment of the Secretariat is indicative of Africa's resolve to eliminate PPR and will serve as a mechanism for orchestrating PPR eradication efforts across the African continent by the year 2030. (au-ibar.org)
  • The Secretariat of the Pan-African Secretariat for PPR Eradication in Africa is situated at AU-IBAR, located in Nairobi, Kenya. (au-ibar.org)
  • The African Union is presently engaging with Ministers of Agriculture and Animal Resources to solicit their assistance in mobilising resources for the establishment of the Pan African Secretariat for the Eradication of PPR by the year 2030. (au-ibar.org)
  • The commencement of the Pan African PPR Eradication Programme (2022-2026) was concomitant with the Nairobi Declaration on the Eradication of PPR. (au-ibar.org)
  • It emphasises the need to prevent the persistence of the disease in Africa from impeding the global eradication target set for 2030. (au-ibar.org)
  • The initial stage (2017-2021) of the Pan African PPR control and eradication initiative garnered backing from the European Union and other partners, indicating a clear demonstration of additional investment. (au-ibar.org)
  • The European Union has demonstrated a positive attitude towards investing in the current phase of the Pan Africa PPR eradication programme by expressing their intention to allocate a sum of Euro 100 million. (au-ibar.org)
  • Animal trypanosomiasis remains a major constraint to livestock production in sub-Saharan Africa despite various strategies employed to control, treat and eradicate the disease. (biomedcentral.com)
  • Pentamidine isethionate and suramin (under an investigational New Drug Protocol from the CDC Drug Service) are the drugs of choice to treat the hemolymphatic stages of West and East African Trypanosomiasis , respectively. (wikidoc.org)
  • It was found that the incidence of bovine trypanosomiasis is high. (gla.ac.uk)
  • Bovine trypanosomiasis susceptibility of East African cattle to African trypanosomiasis / by Monirei, Joseph Meeli. (who.int)
  • The disease does not occur in the United States, but travelers who have visited or lived in Africa can get infected. (medlineplus.gov)
  • Nagana is a rapidly fatal trypanosomiasis of horses and other animals. (sdsu.edu)
  • Trypanosomiasis affects man and his domestic Livestock in 10 million km2 of tropical Africa. (gla.ac.uk)
  • Livestock plays a vital role in ensuring food security, livelihoods, and incomes in Africa. (au-ibar.org)
  • The RAFFS project aims to make a significant contribution to food security and nutrition in Africa by ensuring that Africa's livestock sector continues to provide a sustainable source of food, livelihoods and income for millions of people. (au-ibar.org)
  • Animal African trypanosomiasis (AAT) greatly affects livestock production in sub-Saharan Africa. (biomedcentral.com)
  • Other animals, such as cows, may carry the disease and become infected in which case it is known as Nagana or animal trypanosomiasis. (wikipedia.org)
  • 1998). Direct parasitological diagnosis of trypanosomiasis is based on the trypomastigotes forms detection in fresh blood samples or blood smear by microscopic examination. (vin.com)
  • In both early- and late-stage trypanosomiasis, symptoms usually resolve after treatment, and the parasitemia clears on repeat blood smears. (medscape.com)
  • Medical treatment of African trypanosomiasis should begin as soon as possible and is based on the infected person's symptoms and laboratory results. (wikidoc.org)
  • Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case-control study. (seattlechildrens.org)
  • The project, called Resilient African Feed and Fodder Systems (RAFFS), will run for three years from December 2022 to December 2025. (au-ibar.org)
  • Available at https://www.ema.europa.eu/documents/smop-initial/chmp-summary-opinion-fexinidazole-winthrop_en.pdf . (medscape.com)
  • Numerous actions have been performed in regard to the PPR Strategy both before and after the establishment of the Pan-Africa PPR Programme (2022-2026) and the public unveiling of the Programme by the Ministers in Charge of Animal Resources on the 17th March, 2022. (au-ibar.org)
  • 4 Centre International de Recherche-Développement sur l'Elevage en Zone Subhumide (CIRDES), Bobo-Dioulasso, Burkina Faso . (scirp.org)
  • If a person fails to receive medical treatment for African trypanosomiasis , death will occur within several weeks to months. (wikidoc.org)
  • is a microbial vector driven disease that affects many parts of Africa. (kenyon.edu)
  • exported cases also have been reported in expatriates, immigrants, refugees to countries outside of Africa, and tourists. (cdc.gov)
  • Tourists and other people working in or visiting game parks are at risk for contracting African trypanosomiasis if they spend long periods in rural areas where the disease is present. (cdc.gov)
  • Three major outbreaks have occurred in recent history: one from 1896 to 1906 primarily in Uganda and the Congo Basin, and two in 1920 and 1970, in several African countries. (wikipedia.org)
  • Tsetse flies are found just in sub-Saharan Africa though only certain species transmit the disease. (who.int)
  • Tsetse flies inhabit rural areas, living in the woodlands and thickets that dot the East African savannah. (medscape.com)
  • Risk factors include living in parts of Africa where the disease is found and being bitten by tsetse flies. (medlineplus.gov)
  • It only occurs in 36 countries of the African Region and places over 60 million people at risk. (who.int)
  • This graph shows the total number of publications written about "Trypanosomiasis, African" by people in this website by year, and whether "Trypanosomiasis, African" was a major or minor topic of these publications. (sdsu.edu)
  • Below are the most recent publications written about "Trypanosomiasis, African" by people in Profiles. (sdsu.edu)
  • The majority of the world's SCD burden is in sub-Saharan Africa, affecting millions of people at all ages. (nature.com)
  • Central African Republic, Chad and South Sudan declared between 100 and 500 new cases in 2012. (who.int)
  • He further informed the audience that AU-IBAR is also promoting policy dialog at national level, through the reinforcing veterinary governance in Africa programme. (au-ibar.org)
  • The recommendation urged the African Union Commission, AUDA-NEPAD, RECs, and Member States, with the support of FAO, WOAH and stakeholders to expedite their endeavours in mobilising resources for a programme that is coordinated at the continental level. (au-ibar.org)
  • The disease occurs regularly in some regions of sub-Saharan Africa with the population at risk being about 70 million in 36 countries. (wikipedia.org)
  • The study indicated that the efficacy of current chemotherapeutic regime in Zambia should be critically examined and that more information on the incidence of animal trypanosomiasis is required. (gla.ac.uk)
  • In his welcoming remarks, The Director of AU-IBAR Prof Ahmed Elsawalhy informed participants that the African Union, through the Interafrican Bureau for Animal Resources (IBAR) has significantly improved the participation of African delegates in the activities of international organizations responsible for the development of international sanitary and Phytosanitary standards (OIE, Codex, IPPC) as well as their participation in the meetings of the SPS Committee. (au-ibar.org)
  • The African Union-InterAfrican Bureau for Animal Resources (AU-IBAR) and the Bill & Melinda Gates Foundation (BMGF) are working together to build resilience in African feed and fodder systems. (au-ibar.org)